- HCQ studies
- Why They’re Denying You Healthcare And Financial Support During A Pandemic
- Fewer Jobs, Rising Poverty: Scathing Report Finds Trump Economic Legacy ‘One of the Worst Among All US Presidents’
- A New Satellite Can Peer Inside Buildings, Day or Night
- Operation Amazônia: Brazilian Army “simulates war” with Venezuela
- Andrew Yang Calls For Bar Codes to Identify People Who Have Been Vaccinated
- CIA’S Afghan Death Squads: A US Backed Militia that Kills Children May Be America’s Exist Strategy
- A Return to Normalcy? Joe Biden’s Vision of Normal Raises Concerns
- Pandemic Crash Shows Worker Co-ops Are More Resilient Than Traditional Business
- Corrupt Science and Elite Power: Covid-19 “Techno-Slavery” and the “Great Reset” Are Now Imminent
- Study: “Cancel Culture” Decimating Free Speech At World’s Leading Universities
- Chris Hedges: The Great Delusion
- New nature lover? It’s a COVID-19 side effect
- International Journal of Antimicrobial Agents
- Amazing to learn the Covid although real in some aspects appears to used by political hacks for control.
- The diversity of Biden’s cabinet will be just for show if it ends up promoting bad policies
- Crime Shouldn’t Pay: Why Big Tech Executives Should Face Jail
- The Coronavirus Vaccine Could Be the Ultimate Gateway Drug
- Are GM plants with Bt toxins 20 times more toxic than previously known?
- Biden’s pick for agriculture secretary raises serious red flags
- How the American child welfare system lost its way
- Biden Taps Bruce Reed, Deficit Hawk and Longtime Enemy of Social Security, for Deputy Chief of Staff
- Archive of 4,000 Documents Reveals Government Knew Decades Ago About Health Impact of Wireless Technology
- Medicare Fraudster Who Exploited the Elderly in $1.3 Billion Scheme Embodies ‘Grotesque’ Corruption of Trump Clemency Orders
- The Top 10 Extreme Weather and Climate Events of 2020
- Organic meat production just as bad for climate, study finds
- The DC Political Monopoly Just Doesn’t Get It
- We’re Outsourcing Our Self-Awareness to Silicon Valley
- Model used to evaluate lockdowns was flawed
- New study shows coronavirus capable of entering the brain, has similarities to HI
- ‘If You Own the Seeds You Own the Food System’: Campaigners Demand Public Ownership to Counter Big Ag Privatization
- The US Government Can Provide Universal Childcare — It’s Done So in the Past
- New Study Shows Mask Mandates Had Zero Effect in Florida or Nationwide, But the Lie Continues
- The ‘Moderate’ Rot at the Top of the Democratic Party
- The Threat of Authoritarianism in the U.S. is Very Real, and Has Nothing To Do With Trump
- New York Lawmakers Poised to Pass Nation’s Strongest Eviction Ban as Millions Face Housing Insecurity
- Selling Weapons – The Most Corrupt Industry in the World
- Inviting Nuclear Disaster
- The American System Is One Big Grift
- Lethal Levels of Radiation Found in Damaged Fukushima Reactor Will Have ‘Huge Impact’ on Shutdown, Regulators Warn
- CRISPR gene editing causes chaos in the genome
- UC researcher urges caution using remdesivir to treat COVID-19
videos
Exploring the glucose-lowering composition and mechanisms of tea
Anhui Agricultural University (China), December 28, 2020
According to news reporting originating from Hefei, People’s Republic of China, research stated, “Tea, a widely consumed beverage, has long been utilized for promoting human health with a close correlation to hyperglycemia.”
The news journalists obtained a quote from the research from Anhui Agricultural University: “The Tea Metabolome Database (TMDB), the most complete and comprehensive curated collection of tea compounds data containing 1271 identified small molecule compounds from the tea plant (Camellia sinensis), was established previously by our research team. More recently, our studies have found that various tea types possess an antihyperglycemic effect in mice. However, the bioactive ingredients from tea have potential antihyperglycemic activity and their underlying molecular mechanisms remain unclear. In this study, we used a molecular docking approach to investigate the potential interactions between a selected 747 constituents contained in tea and 11 key protein targets of clinical antihyperglycemic drugs. According to our results, the main antihyperglycemic targets of tea composition were consistent with those of the drug rosiglitazone. The screening results showed that GCG, ECG3’Me, TMDB-01443, and CG had great target binding capacity.”
According to the news reporters, the research concluded: “The results indicated that these chemicals of tea might affect hyperglycemia by acting on protein targets of rosiglitazone.”
Differential inhibition of gelatinase activity in human colon adenocarcinoma cells by Aloe vera extracts
University of Lisbon (Portugal), December 24, 2020
Background
Aloe’s reported bioactivities (anticancer, anti-inflammatory and wound healing) suggest they might inhibit a subgroup of matrix metalloproteinases (MMPs) called gelatinases (MMP-2 and MMP-9). The goal of the present study was to compare the MMP inhibitory potential of two Aloe species, A. vera and A. arborescens.
Methods
Different types of extraction were tested and specific bioactive compounds were quantified. Cancer cell invasion inhibitory activities were measured in vitro using the wound healing assay in human colon cancer cells (HT29). Effects on gelatinase activities were further assessed by dye-quenched gelatin and gelatin zymography.
Results
Different types of extraction yielded significantly different levels of bioactivities and of bioactive compounds, which might be due to a greater amount of extractable bioactive compounds such as anthraquinones. Both A. arborescens and A. vera have potential as inhibitory agents in cancer cell proliferation via MMP-9 and MMP-2 enzymatic activity inhibition, being able to reduce colon cancer cell proliferation and migration but A. arborescens showed to be a more effective inhibitor of cancer cell migration than A. vera.
Conclusion
This work opens novel perspectives on the mode of action of Aloe species in cancer cell migration and may provide clues as to why there are so many conflicting results on Aloe’s activities.
Brain imaging study pinpoints neurotransmitter that may be responsible for yoga’s mood-boosting effect
Boston University, December 29, 2020
A recent study found tentative evidence to suggest that yoga exerts its mood-boosting effect by increasing GABA activity among individuals with depression. The study, published in the Journal of Alternative and Complementary Medicine, further suggests that yoga’s beneficial effects on mood are time-limited.
While medication can be highly effective in reducing symptoms of major depressive disorder (MDD), many individuals do not reach remission without additional treatment. Interestingly, yoga interventions have shown promise in reducing depressive symptoms, although it is not clear why.
“Integrative medicine includes consideration of the mind-body interface. Yoga can be used to address many form of illness especially those due to Life Style Choices,” said study author Chris C. Streeter, an associate professor of psychiatry and neurology at the Boston University School of Medicine.
“Many form of western medicine help reduce symptoms but to do completely return people to wellness, the addition of yoga to a treatment regime can increase wellness/decrease symptoms.”
Streeter and her colleagues set out to explore the idea that a yoga intervention increases mood through its effect on an amino acid neurotransmitter called gamma-aminobutyric acid (GABA). The researchers were motivated by findings linking the neurotransmitter to depression. Specifically, insufficiency in the GABA system has been linked to depressive symptoms, and individuals with MDD have been found to have low GABA levels. On the other hand, yoga interventions have been purported to increase GABA activity.
Streeter and team recruited 32 adults with MDD for a 12-week yoga intervention. Patients were assigned to either a high-dose intervention of three yoga sessions a week or a low-dose intervention of two yoga sessions a week. The yoga sessions included 60 minutes of Iyengar yoga, 10 minutes of relaxation, 20 minutes of breathing practice, and homework exercises.Throughout the study, the patients underwent magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) scans before the 12-week intervention and following the intervention. At the end of the intervention, all participants took part in an additional 90-minute yoga session and then a third and final brain scan.
The researchers found that the overall direction of the data when considering all participants, pointed to increases in GABA levels between the first and last scans, and the second and third scans. However, there were no differences between the high-dose yoga and low-dose yoga groups.
The findings provide evidence that “yoga is a low cost, low side effect means of improving mood and decreasing anxiety,” Streeter told PsyPost.
The researchers did find that the number of days since a subject’s latest yoga class appeared to be important, perhaps more so than the amount of yoga practice. Specifically, those who showed increased GABA levels at Scan 2 compared to Scan 1, had an average of 3.93 days since their last yoga session. Those whose GABA levels did not go up had an average of 7.83 days since their last yoga session.
“It is probable that the effects of yoga sessions, like pharmacologic treatments, are time limited,” the researchers remark. “The yoga tradition advocates daily practice. The increase in GABA levels seen after a yoga intervention was observed after an average of 4 days, but no longer observed after an average of 8 days.”
The participants had also completed assessments of depressive symptoms at various timepoints. The researchers found that subjects’ GABA levels were not significantly linked to their depressive symptoms. However, changes in depressive symptoms were inversely tied to GABA levels among the high-dose group. As the authors say, this means that depressive symptoms dropped as GABA levels rose. With a very small sample size, the authors express that their findings are encouraging yet tentative, and future studies should explore the topic among a larger sample.
“The use of yoga for depression needs to be compared to antidepressants in a randomized controlled trial and in combination with anti-depressants,” Streeter said.
Still, the findings suggest that the GABA system may be a mechanism through which yoga improves mood, and practicing yoga at least one time a week may be the key to seeing these benefits.
“There are no magic bullets or pills that completely treat depression or anxiety — yoga is another tool available,” Streeter added. “Many stress-related disorders are associated with an imbalance in the autonomic nervous system with too much sympathetic (fight or flight) and to little parasympathetic (rest, renewal and social engagement). Yoga helps to correct this imbalance.”
The study, “Thalamic Gamma Aminobutyric Acid Level Changes in Major Depressive Disorder After a 12-Week Iyengar Yoga and Coherent Breathing Intervention”, was authored by Chris C. Streeter, Patricia L. Gerbarg, Richard P. Brown, Tammy M. Scott, Greylin H. Nielsen, Liz Owen, Osamu Sakai, Jennifer T. Sneider, Maren B. Nyer, and Marisa M. Silveri.
Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19
University of Otago (New Zealand) and Swansea University Medical School (UK), December 7, 2020
Abstract
There are limited proven therapies for COVID-19. Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19. This literature review focuses on vitamin C deficiency in respiratory infections, including COVID-19, and the mechanisms of action in infectious disease, including support of the stress response, its role in preventing and treating colds and pneumonia, and its role in treating sepsis and COVID-19. The evidence to date indicates that oral vitamin C (2–8 g/day) may reduce the incidence and duration of respiratory infections and intravenous vitamin C (6–24 g/day) has been shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical ventilation for severe respiratory infections. Further trials are urgently warranted. Given the favourable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in respiratory infections, it may be worthwhile testing patients’ vitamin C status and treating them accordingly with intravenous administration within ICUs and oral administration in hospitalised persons with COVID-19.
Conclusions
Vitamin C’s potential benefits, low cost, safety profile and multiple disease-modifying actions, including antioxidant, anti-inflammatory and immunomodulating effects, make it an attractive therapeutic candidate in reducing viral load with oral supplementation in the range of 2–8 g/day to help attenuate the conversion to the critical phase of COVID-19. Likewise, vitamin C has potential benefits in treating acute respiratory infections and mitigating inflammation in critical COVID-19 patients with intravenous vitamin C infusion in the range of 6–24 g/day, for correcting disease-induced deficiency, reducing inflammation, enhancing interferon production and supporting the anti-inflammatory actions of glucocorticosteroids, especially given the high level of fatality for patients with severe COVID-19.
Given the remarkable safety of vitamin C, frequent deficiency among patients with COVID-19 and extensive evidence of potential benefits, the current treatment is justified on compassionate grounds pending more COVID-19 clinical trial data becoming available, not only for intravenous use within ICUs, but also orally with doses between 2 and 8 g/day in hospitalised patients due to increased need when fighting a viral infection, as concluded in recent reviews [36,117,118]. The clinical choice of oral versus intravenous vitamin C may be guided by similar criteria for administering oral versus intravenous antibiotics, considering both the severity of the illness and whether the patient is able to swallow oral medication at least four times a day.
People in high-risk groups for COVID-19 mortality, and at risk of vitamin C deficiency, should be encouraged to supplement with vitamin C daily to ensure vitamin C adequacy at all times, and to increase the dose when virally infected to up to 6–8 g/day [119]. Whether or not this will prevent conversion to the critical phase of COVID-19 has yet to be determined.
Catechins from oolong tea improve uterine defects by inhibiting STAT3 signaling in polycystic ovary syndrome mice
Peking Union Medical College, December 22, 2020
Background
It is showed that inflammation is causative factor for PCOS, leading to a decline in ovarian fertility. Previous studies have reported that tea consumption can reduce the incidence of ovarian cancer. We speculate that catechins from oolong tea (Camellia sinensis (L.) O.Kuntze) may have a potential therapeutic effect on PCOS. This study aims to investigate the effects of oolong tea catechins on the uterus of polycystic ovary syndrome (PCOS) mice induced by insulin combined with human chorionic gonadotropin (hCG).
Methods
Sixty female mice were divided into 6 groups (n = 10): model, model + Metformin 200 mg/kg, model + catechins 25 mg/kg, model + catechins 50 mg/kg, and model + catechins 100 mg/kg. Another forty female mice were divided into 4 groups (n = 10): control, control + catechins 100 mg/kg, model, and model + catechins 100 mg/kg. Ovarian and uterine weight coefficients, sex hormone levels, glucose metabolism and insulin resistance, and ovarian and uterine pathology were examined. Changes in NF-κB-mediated inflammation, MMP2 and MMP9 expressions, and STAT3 signaling were evaluated in the uterus of mice.
Results
Catechins could effectively reduce the ovarian and uterine organ coefficients, reduce the levels of E2, FSH and LH in the blood and the ratio of LH/FSH, and improve glucose metabolism and insulin resistance in PCOS mice induced by insulin combined with hCG. In addition, catechins could significantly down-regulated the expression of p-NF-κB p65 in the uterus and the protein expressions of the pro-inflammatory factors (IL-1β, IL-6, and TNF-α). The expressions of mmp2 and mmp9 associated with matrix degradation in uterine tissue were also significantly down-regulated by catechins. Further, catechins significantly reduced the expression of p-STAT3 and increased the expression of p-IRS1 and p-PI3K in the uterus of PCOS mice.
Conclusion
Catechins from oolong tea can alleviate ovarian dysfunction and insulin resistance in PCOS mice by inhibiting uterine inflammation and matrix degradation via inhibiting p-STAT3 signaling.
Research suggests prenatal carnitine supplementation could help prevent autism
Texas A&M University, December 22, 2020.
An article appearing in the journal Cell Reports reveals the finding of researchers at Texas A&M Health Science Center College of Medicine of a potential role for carnitine as a prenatal supplement to protect against a variety of autism in unborn children.
Carnitine, found in meat and other foods, is also manufactured in the body from the amino acid lysine. Research has shown that inherited mutations in a gene (TMLHE) required for carnitine synthesis are associated with development of autism spectrum disorders, yet the mechanism supporting the relationship had not been established.
By utilizing technology that allows tracking of individual neural stem cells in a developing brain, Zhigang Xie, PhD, and colleagues observed that cells that fail to produce carnitine are depleted; however, this phenomenon is prevented when the neural stem cells are supplied with carnitine. “We suggest that genetic screening of prospective parents for TMLHE mutations, coupled with inclusion of carnitine as a dietary supplement upon initial diagnosis of pregnancy, promises mental health benefits for newborns otherwise at significant risk for developmental brain disorders,” the authors conclude.
“Here we have indications, at least for some types of autism risk, that a dietary carnitine prevention method might be effective,” Dr Xie commented. “For some individuals, this simple nutritional supplement might really help reduce the risk of developing autism spectrum disorder. Any progress on the prevention front would be welcome given the number of people affected.”
“While it could work in cases involving carnitine-deficiency, other pathways are also in play because as many as 1000 genes might ultimately be found to relate to autism risk,” Dr Xie added. “Still, the potential impact of even such a limited preventive strategy could be significant as mutant TMLHE alleles are surprisingly common in the human population.”
Higher dietary fiber intake in young women may reduce breast cancer risk
Harvard School of Public Health, December 19, 2020
Boston, MA – Women who eat more high-fiber foods during adolescence and young adulthood–especially lots of fruits and vegetables–may have significantly lower breast cancer risk than those who eat less dietary fiber when young, according to a new large-scale study led by researchers at Harvard T.H. Chan School of Public Health.
The study will be published online in Pediatrics.
“Previous studies of fiber intake and breast cancer have almost all been non-significant, and none of them examined diet during adolescence or early adulthood, a period when breast cancer risk factors appear to be particularly important,” said Maryam Farvid, visiting scientist at Harvard Chan School and lead author of the study. “This work on the role of nutrition in early life and breast cancer incidence suggests one of the very few potentially modifiable risk factors for premenopausal breast cancer.”
The researchers looked at a group of 90,534 women who participated in the Nurses’ Health Study II, a large long-running investigation of factors that influence women’s health. In 1991, the women–ages 27-44 at the time–filled out questionnaires about their food intake, and did so every four years after that. They also completed a questionnaire in 1998 about their diet during high school. The researchers analyzed the women’s fiber intake while adjusting for a number of other factors, such as race, family history of breast cancer, body mass index, weight change over time, menstruation history, alcohol use, and other dietary factors.
Breast cancer risk was 12%-19% lower among women who ate more dietary fiber in early adulthood, depending on how much more they ate. High intake of fiber during adolescence was also associated with 16% lower risk of overall breast cancer and 24% lower risk of breast cancer before menopause. Among all the women, there was a strong inverse association between fiber intake and breast cancer incidence. For each additional 10 grams of fiber intake daily–for example, about one apple and two slices of whole wheat bread, or about half a cup each of cooked kidney beans and cooked cauliflower or squash–during early adulthood, breast cancer risk dropped by 13%. The greatest apparent benefit came from fruit and vegetable fiber.
The authors speculated that eating more fiber-rich foods may lessen breast cancer risk partly by helping to reduce high estrogen levels in the blood, which are strongly linked with breast cancer development.
“From many other studies we know that breast tissue is particularly influenced by carcinogens and anticarcinogens during childhood and adolescence,” said Walter Willett, Fredrick John Stare Professor of Epidemiology and Nutrition at Harvard Chan School and senior author of the study. “We now have evidence that what we feed our children during this period of life is also an important factor in future cancer risk.”
High homocysteine, vitamin deficiencies more common in cognitively impaired adults
Medical University of Havana (Cuba), December 28 2020.
The October 2020 issue of MEDICC Review published the finding of Cuban researchers of a greater incidence of high homocysteine levels and low levels of several vitamins among older men and women with mild cognitive impairment or Alzheimer disease.
The study included 43 Alzheimer disease patients, 131 individuals with mild cognitive impairment and 250 subjects without cognitive impairment who participated in Cuba’s Aging and Alzheimer Study. Blood samples were analyzed for levels of vitamins A, B1, B2, B12, C and folate, and homocysteine.
Compared to the cognitively healthy group, Alzheimer disease patients had over five times the prevalence of vitamin A deficiency, nearly two times the rate of being deficient in vitamin B1, nearly three times the rate of B2 deficiency, more than double the rate of vitamin B12 deficiency, nearly four times the rate of vitamin C deficiency, three times the rate of folate deficiency, and more than three times the rate of elevated homocysteine levels. Subjects with mild cognitive impairment also had a greater risk of having high homocysteine and deficiencies in vitamins A and B2.
“This is the first study in Cuba to examine vitamin and homocysteine levels in older adults with Alzheimer disease or mild cognitive impairment, and results show a relationship between these nutritional indicators and the cognitive disorders,” authors Yeneisy Lanyau-Domínguez, MS, PhD, and colleagues announced.
They remarked that the availability of antioxidant vitamins is decreased in cognitive disorders due to oxidative stress, which increases the body’s antioxidant requirement. Furthermore, deficient B vitamin levels due to insufficient intake is a cause of high homocysteine in older adults, which can contribute to cognitive impairment and Alzheimer disease through several mechanisms.
“Longitudinal studies are needed to further understand the relationship between different nutritional biomarkers and dementia,” they recommended.
Junk food linked to sleep problems in teens
University of Queensland (Australia), December 23, 2020
Eating too much junk food has been linked with poor sleep quality in teens, a University of Queensland-led study has found.
UQ School of Health and Rehabilitation Sciences researcher Associate Professor Asad Khan said frequent consumption of soft drinks and fast food was strongly associated with sleep disturbance in adolescents around the world.
“This is the first study to examine unhealthy diets and stress-related sleep disturbance on a global scale in high school students from 64 countries,” Dr. Khan said.
“Overall, 7.5 percent of adolescents reported stress-related sleep disturbance, which was more common among females than males.
“Sleep disturbance increased with more frequent consumption of carbonated soft drinks, that often contain caffeine, and/or fast foods, that are traditionally energy-dense and nutrient-poor.
“Teens who drank more than three soft drinks per day had 55 percent higher odds of reporting sleep disturbance than those who only drank one soft drink a day.
“Males who ate fast foods on more than four days per week had 55 percent higher odds of reporting sleep disturbance than those who only ate fast food once a week, while the odds were 49 percent higher in females.
“Frequent consumption of soft drinks more than three times a day, and fast foods more than four days per week, were significantly associated with sleep disturbance in all but low-income countries.”
Data was collected from the World Health Organization’s Global School-based Health Surveys between 2009 and 2016, which included 175,261 students aged 12 to 15 years from 64 low, middle, and high income countries across South East Asia, Africa, parts of South America and the Eastern Mediterranean.
“Teens in high-income countries had the highest association between frequent intake of soft drinks and sleep disturbance,” Dr. Khan said.
“Females in these countries showed the biggest connection between regularly eating fast foods and sleep problems.
“Adolescents in South-Asia showed a high connection between drinking soft drink and sleep disturbance, while those in the Western-Pacific region showed the greatest link between both soft drink and fast food consumption and sleep issues.”
Dr. Khan said the findings were of particular concern as poor quality sleep adversely impacted on adolescent wellbeing and cognitive development.
“The targeting of these unhealthy behaviors needs to be a priority of policies and planning,” he said.
“Strategies need to be customized and tailored across countries or regions to meet their local needs.
“As stress-related sleep disturbance was more common among girls than boys, girls should be a priority target group for associated interventions that could target stress management and sleep quality.
“Creating school environments to limit access to carbonated soft drinks and fast foods, and introducing a sugar tax to lessen the sales of soft drinks may be beneficial.
“Family can also be instrumental in promoting healthy eating as the adoption and maintenance of children’s dietary behaviors are influenced by their familial environments.”
Antimicrobial activity of rosemary leaf extracts and efficacy of ethanol extract against testicular damage caused by 50-Hz electromagnetic field
Minia University (Egypt), May 27, 2020
Rosemary is a restorative plant that has numerous utilizations in traditional medicine. In this investigation, rosemary leaf extracts were examined for their antimicrobial and antioxidant activities. The antimicrobial activity was tested against 8 bacterial strains. The antioxidant feature of rosemary extract on rat testicular tissue after exposure to the electromagnetic field. Sixty adult male albino rats weighing 180-200 g (aged 2 months) were divided into six groups: control group, rosemary group (receiving rosemary extract at a dose of 5 mg/kg b.wt), EMF (2 h) group (exposed to 50 Hz and 5.4 kV per meter of magnetic field for 2 h), EMF (4 h) group (exposed to 50 Hz and 5.4 kV per meter of magnetic field for 4 h), EMF (2 h) + rosemary group (receiving both magnetic field for 2 h and extract), and EMF (4 h) + rosemary group (receiving both magnetic field for 4 h and extract). After 30 days, the rats were sacrificed, and some estimates were determined. Results exhibited that the ethanolic extract of rosemary leaves was active against pathogenic bacteria. Results also demonstrated that exposure to EMF diminished level of male hormones (e.g., follicle stimulating hormone (FSH), testosterone, and luteinizing hormone (LH)) in serum and catalase (CAT) activity remarkably and increased the malondialdehyde (MDA) levels in comparison to the control group. Signs of improvement in the male hormones, CAT activity, and MDA levels were noticed during the treatments with rosemary. Histological results showed that the rosemary extract inhibited the destructive effect of electromagnetic fields on testicular tissue. This research reveals that the ethanolic extract of rosemary has many beneficial effects that can be compelling in supporting individuals living with EMF ecological contamination.
Research conducted at University of North Texas has provided new information about food science
University of North Texas, December 26, 2020
According to news reporting out of Denton, Texas, research stated, “Botanical supplements derived from grapes are functional in animal model systems for the amelioration of neurological conditions, including cognitive impairment. Rats fed with grape extracts accumulate 3’–methyl-quercetin-3–b-d-glucuronide () in their brains, suggesting as a potential therapeutic agent.”
Our news journalists obtained a quote from the research from the University of North Texas, “To develop methods for the synthesis of and the related 4’–methyl-quercetin-7–b-d-glucuronide (), 3–methyl-quercetin-3’–b-d-glucuronide (), and 4’–methyl-quercetin-3’–b-d-glucuronide (), which are not found in the brain, we have evaluated both enzymatic semisynthesis and full chemical synthetic approaches. Biocatalysis by mammalian UDP-glucuronosyltransferases generated multiple glucuronidated products from 4’–methylquercetin, and is not cost-effective. Chemical synthetic methods, on the other hand, provided good results; , and were obtained in six steps at 12, 18, and 30% overall yield, respectively, while was synthesized in five steps at 34% overall yield.”
According to the news editors, the research concluded: “A mechanistic study on the unexpected regioselectivity observed in the quercetin glucuronide synthetic steps is also presented.”
This research has been peer-reviewed.
One psychedelic experience may lessen trauma of racial injustice
Ohio State University, December 28, 2020
A single positive experience on a psychedelic drug may help reduce stress, depression and anxiety symptoms in Black, Indigenous and people of color whose encounters with racism have had lasting harm, a new study suggests.
The participants in the retrospective study reported that their trauma-related symptoms linked to racist acts were lowered in the 30 days after an experience with either psilocybin (Magic Mushrooms), LSD or MDMA (Ecstasy).
“Their experience with psychedelic drugs was so powerful that they could recall and report on changes in symptoms from racial trauma that they had experienced in their lives, and they remembered it having a significant reduction in their mental health problems afterward,” said Alan Davis, co-lead author of the study and an assistant professor of social work at The Ohio State University.
Overall, the study also showed that the more intensely spiritual and insightful the psychedelic experience was, the more significant the recalled decreases in trauma-related symptoms were.
A growing body of research has suggested psychedelics have a place in therapy, especially when administered in a controlled setting. What previous mental health research has generally lacked, Davis noted, is a focus on people of color and on treatment that could specifically address the trauma of chronic exposure to racism.
Davis partnered with co-lead author Monnica Williams, Canada Research Chair in Mental Health Disparities at the University of Ottawa, to conduct the research.
“Currently, there are no empirically supported treatments specifically for racial trauma. This study shows that psychedelics can be an important avenue for healing,” Williams said.
The study is published online in the journal Drugs: Education, Prevention and Policy.
The researchers recruited participants in the United States and Canada using Qualtrics survey research panels, assembling a sample of 313 people who reported they had taken a dose of a psychedelic drug in the past that they believed contributed to “relief from the challenging effects of racial discrimination.” The sample comprised adults who identified as Black, Asian, Hispanic, Native American/Indigenous Canadian, Native Hawaiian and Pacific Islander.
Once enrolled, participants completed questionnaires collecting information on their past experiences with racial trauma, psychedelic use and mental health symptoms, and were asked to recall a memorable psychedelic experience and its short-term and enduring effects. Those experiences had occurred as recently as a few months before the study and as long ago as at least 10 years earlier.
The discrimination they had encountered included unfair treatment by neighbors, teachers and bosses, false accusations of unethical behavior and physical violence. The most commonly reported issues involved feelings of severe anger about being subjected to a racist act and wanting to “tell someone off” for racist behavior, but saying nothing instead.
Researchers asked participants to recall the severity of symptoms of anxiety, depression and stress linked to exposure to racial injustice in the 30 days before and 30 days after the experience with psychedelic drugs. Considering the probability that being subjected to racism is a lifelong problem rather than a single event, the researchers also assessed symptoms characteristic of people suffering from discrimination-related post-traumatic stress disorder (PTSD).
“Not everybody experiences every form of racial trauma, but certainly people of color are experiencing a lot of these different types of discrimination on a regular basis,” said Davis, who also is an adjunct faculty member in the Johns Hopkins University Center for Psychedelic and Consciousness Research. “So in addition to depression and anxiety, we were asking whether participants had symptoms of race-based PTSD.”
Participants were also asked to report on the intensity of three common kinds of experiences people have while under the influence of psychedelic drugs: a mystical, insightful or challenging experience. A mystical experience can feel like a spiritual connection to the divine, an insightful experience increases people’s awareness and understanding about themselvess, and a challenging experience relates to emotional and physical reactions such as anxiety or difficulty breathing.
All participants recalled their anxiety, depression and stress symptoms after the memorable psychedelic experience were lower than they had been before the drug use. The magnitude of the positive effects of the psychedelics influenced their reduction in symptoms.
“What this analysis showed is that a more intense mystical experience and insightful experience, and a less intense challenging experience, is what was related to mental health benefits,” Davis said.
The researchers noted in the paper that the study had limitations because the findings were based on participant recall and the entire sample of recruited research volunteers had reported benefits they associated with their psychedelic experience – meaning it cannot be assumed that psychedelics will help all people of color with racial trauma. Davis and Williams are working on proposals for clinical trials to further investigate the effects of psychedelics on mental health symptoms in specific populations, including Black, Indigenous and people of color.
“This was really the first step in exploring whether people of color are experiencing benefits of psychedelics and, in particular, looking at a relevant feature of their mental health, which is their experience of racial trauma,” Davis said. “This study helps to start that conversation with this emerging treatment paradigm.”
Is there such a thing as an emotional hangover? Researchers find that there is
Rice University, December 26, 2020
Emotional experiences can induce physiological and internal brain states that persist for long periods of time after the emotional events have ended, a team of New York University scientists has found. This study, which appears in the journal Nature Neuroscience, also shows that this emotional “hangover” influences how we attend to and remember future experiences.
“How we remember events is not just a consequence of the external world we experience, but is also strongly influenced by our internal states—and these internal states can persist and color future experiences,” explains Lila Davachi, an associate professor in NYU’s Department of Psychology and Center for Neural Science and senior author of the study.
” ‘Emotion’ is a state of mind,” Davachi continues. “These findings make clear that our cognition is highly influenced by preceding experiences and, specifically, that emotional brain states can persist for long periods of time.”
We have known for quite some time that emotional experiences are better remembered than non-emotional ones. However, in the Nature Neuroscience study, the researchers demonstrated that non-emotional experiences that followed emotional ones were also better remembered on a later memory test.
To do so, subjects viewed a series of scene images that contained emotional content and elicited arousal. Approximately 10 to 30 minutes later, one group then also viewed a series of non-emotional, ordinary scene images. Another group of subjects viewed the non-emotional scenes first followed by the emotional ones. Both physiological arousal, measured in skin conductance, and brain activity, using fMRI, were monitored in both groups of subjects. Six hours later, the subjects were administered a memory test of the images previously viewed.
The results showed that the subjects who were exposed to the emotion-evoking stimuli first had better long-term recall of the neutral images subsequently presented compared to the group who were exposed to the same neutral images first, before the emotional images.
The fMRI results pointed to an explanation for this outcome.
Specifically, these data showed that the brain states associated with emotional experiences carried over for 20 to 30 minutes and influenced the way the subjects processed and remembered future experiences that are not emotional.
“We see that memory for non-emotional experiences is better if they are encountered after an emotional event,” observes Davachi.
How earthing saved one man’s life from EMF sickness
Natural Health 365, December 28, 2020
For Stephen Sinatra, discovering a “new frequency” literally made the difference between life and death, and he credits “earthing” – a movement spearheaded by his father, noted integrative cardiologist Dr. Steve Sinatra – for his dramatic recovery.
Proponents of earthing, or “grounding,” say that the technique of contacting the earth in order to absorb its electromagnetic energy can help re-establish our primal connection, reverse harmful electrical charge in the body – and dramatically improve health and well-being.
What earthing can do for YOU – “I immediately got better…”
Step Sinatra agrees wholeheartedly, maintaining that his former lifestyle on Wall Street exposed him to massive radiation due to electromagnetic frequencies originating from the urban cityscape and his almost-constant cell phone use. Sinatra’s adverse effects from EMFs included nasal problems, coughing, congestion, fatigue, and a troubling sensation that something was “not right.”
These effects grew so severe that the younger Sinatra was hospitalized for forty days. After his father, author of “Earthing: The Next Great Medical Discovery,” suggested earthing – which included a program of walking barefoot and sleeping on sheets woven with silver – Step noted that he could feel a “new frequency” restoring him to health.
However, he suffered a relapse when a WIFI system and several cordless phones were installed in the house in which he was staying – demonstrating for him the difference between” good” and “bad” frequencies, and confirming his determination to continue earthing – while avoiding excessive EMFs.
Modern life physically disconnects us from the earth’s natural energy
Earthing proponents say that we are isolated from earth – and its supply of beneficial negative electrons — by our use of non-conductive materials such as rubber and synthetics in the soles of our shoes, as well as rubber-wheeled cars and bicycles, insulated homes and carpeted floors.
Human beings are already positively charged, and we pick up more voltage when our bodies act as antenna for electrical wiring, WIFI networks, cell phones, TVs and microwaves in the vicinity. This high voltage interferes with the body’s abilities to repair itself during sleep, and can cause unhealthy physiological changes – such as increased cortisol.
How “caveman medicine” can help
Walking barefoot on cool, damp sand, or running shoeless over warm, springy summer grass… there’s a reason that these actions feel so undeniably good – to the point that children, and many adults, intuitively seek out these activities and sensations.
According to Dr. Sinatra, putting bare feet to the ground – what he calls “caveman medicine” – is the cheapest, easiest way to soak up the earth’s negatively-charged electrons and combat destructive free radicals in our bodies. Benefits from “draining the charge,” says Dr. Sinatra, can happen within seconds – and are signaled by the sympathetic nervous system shifting to a more tranquil state.
This relaxed state is accompanied by decreases in muscle tension, changes in EEG brain waves and skin conductance.
Various studies performed by the National Institutes of Health have shown that the simple act of making contact with the earth can impart profound and measurable physiological benefits. And, these benefits seem custom-designed to help ward off the chronic degenerative conditions – including heart disease, diabetes and cancer — that currently plague many aging adults in the United States.
Earthing decreases levels of the stress hormone cortisol, reduces inflammation, enhances immune response, improves glucose regulation, and helps oxygenate the blood while reducing its viscosity – thereby helping to curtail risk of cardiovascular disease.
Earthing also delays the onset of muscle soreness after exercising, reduces the perception of pain, and regulates rates of pulse and respiration. Finally, there is evidence that grounding while sleeping – with the use of specialized grounding sheets – can reduce or eliminate sleep dysfunction.
Watch Dr. Steven Sinatra discuss the benefits of grounding – below:
Small lifestyle changes can add up to better health
In addition to grounding whenever possible, you can make lifestyle changes that reduce your exposure to positively-charged EMFs. Step Sinatra advises techniques such as disabling the WIFI button on the laptop when not in use, leaving cell phones on airplane mode for the majority of the day, using the speaker phone option on cell phones, and using a landline – whenever possible. As leather conducts the energy of the earth, wearing leather-soled shoes is also beneficial.
Many devotees of earthing report that they can physically feel a unique, gentle and life-affirming energy charge released during contact with earth – and they have christened it “vitamin G.” If you feel you have a deficiency of “vitamin G,” the solution – contacting the earth – is free, devoid of side effects, completely natural and simple to employ.
5G’s Crime Against Humanity
Richard Gale and Gary Null PhD
Progressive Radio Network, November 3, 2020
For those who may have watched last Sunday’s NFL games, they would have noticed a preponderance of advertisements hearkening the wonderful promises that the large variety of 5G technologies will bring into our lives. The ads tout the interconnectivity of all things and the technological miracle underway. For the casual viewer, it would seem as if life can never be the same without it. It is the new, essential and life-enhancing technology.
However, there are urgent facts solely missing from the networks’ commercials. Fiber optic technology to increase Internet speed has been with us for over a decade. Therefore, speed is not the primary issue on the table. People could have high connectivity and yet not be exposed to 5G’s high EMF levels. Nor would thousands of satellites orbiting the earth be required. No, there is a far more nefarious agenda behind 5G in order to usher in the international globalists’ Fourth Industrial Revolution. The World Economic Forum’s slide presentation, “Why is 5G Important for the Fourth Industrial Revolution,” outlines the multi-trillion dollar impact advanced connectivity will have on manufacturing, wholesale and resale, smart cities and homes, public services, transportation, real time banking, finance and insurance, agriculture and forestry, real estate, education, mining, health and medicine.
Sadly, 5G is destined to be a permanent fixture across the nation. At present, there is barely a chance to prevent it. The thousands of medical and environmental studies warning of high EMF’s dangers and the thousands of international scientists signing petitions to halt its deployment are unequivocally ignored or worse ostracized and cancelled. Despite the pandemic, lockdowns and social distancing have not hindered 5G’s progress to connect every American into its spider’s web. Last December, T-Mobile reached its goal of nationwide coverage of over 1.3 million square miles (34 percent of the US) for its 5G network and AT&T reached its milestone in July, which reaches 179 million people. Nor will tribal lands and federal parks and historic sites be exempt. Trump’s FCC czar and ALEC insider Ajit Pai has pathologized the agency to assure 5G infrastructure build-outs will be expedited in these vulnerable areas.
There are no fundamental differences between Biden and Trump for accelerating the 5G roll out. Both argue that the global race to establish the Internet of Everything is critical for the US to maintain its leadership in the world. Both are also committed to funding and expanding 5G’s high speed broadband into rural areas. Last year, the Trump administration awarded over $744 million “to support more than 80 broadband projects benefiting more than 430,000 rural residents in 34 states.”
In 2016, while running in the shadow of becoming the American Legislative Exchange Council’s president, Trump’s campaign, as expected, won the financial support of the primary 5G players: AT&T, Verizon, Charter Communications, Comcast, Intel and Qualcomm. However, this year the tides tipped enormously toward Biden, who has received $97 million from the Communications/Tech sector versus Trump’s $18 million. Alphabet (Google), Microsoft, Amazon, Facebook, Apple, AT&T and Comcast overwhelmingly contributed to Biden’s war chest.
Amidst all of the hype and endless advertisements to woo Americans into the 5G dream of electronic comforts and efficiencies, the results thus far are rather dismal. There may be more hype than fact. US Today reported that although the telecomm companies are rapidly deploying transmission “lanes,” they must use lower frequencies, which means that speeds are little different than 4G. To gain access to 5G’s speed capabilities requires users to have a technology called mmWave that permits data to be transmitted at higher frequencies. The caveat is that mmWave signals don’t travel far and are highly sensitive to multiple interferences, including walls and windows. You would have to be outside, standing still and in the absence of moving people and vehicles, the article states, to even benefit from it. Verizon relies solely upon mmWave, which are only functional for short distances such as dense urban cities and require more installations; however, measurements seem to indicate that people were only accessing real 5G service 0.4 percent of the time. Furthermore, 5G phones “haven’t been any better than 4G phones.” Or course, in order to undermine these apparent flaws, articles advocating 5G’s benefits are quick to note that the technology is still being developed.
The only major difference is that users are being exposed to more dangerous electromagnetic frequency radiation.
No discussion, no open dialogue and no debate is permitted to conscientiously evaluate this Orwellian phenomenon. Criticisms are censored across the left-right spectrum in network and cable news. Yet for the older generations they have witnessed this charade before. During the first half of the 20th century medical journals and associations advertised tobacco’s benefits. Whether physicians’ preferences were Chesterfield or Lucky Strike did not matter. The message was that smoking was good for us. However, neither a federal agency or the nation’s Surgeon General exposed this lie; rather it was from a whistleblower within the tobacco industry. All of the corporate executives knowingly lied under oath before Congress. Only after this scandal became public did a light bulb switch on about the decades illness and death these lies had perpetuated. Best estimate may be 10 million preventable deaths.
Everyone will be affected by 5G’s radiation. But it will not require three decades to observe its injurious effects. Unlike cigarettes, nobody has a choice whether she or he wishes to be exposed to 5G or not. It is all-pervasive.
This is a consequence of what happens when an entire nation is trapped into carelessly trusting a media empire ruled by serial liars and masters of disinformation campaigns for private corporate interests.
Chris Hedges: The Great Delusion |
By Chris Hedges / Original to ScheerPost
Joe Biden and the systems managers of the deep state and empire are returning to power. Trump and his coterie of buffoons, racists, con artists and Christian fascists are sullenly preparing to leave office. U.S. pharmaceutical corporations are starting to disseminate vaccines to mitigate the globe’s worst outbreak of COVID-19 that has resulted in more than 2,600 deaths per day. America, as Biden says, is back, ready to take its place at the head of the table. In the battle for the soul of America, he assures us, democracy has prevailed. Progress, prosperity, civility and a reassertion of American prestige and power are, we are promised, weeks away.
But the real lesson we should learn from the rise of a demagogue such as Trump, who received 74 million votes, and a pandemic that our for-profit health care industry proved unable to contain, is that we are losing control as a nation and as a species. Far more dangerous demagogues will arise from the imperial and neoliberal policies the Biden administration will embrace. Far worse pandemics will sweep the globe with higher rates of infections and mortality, an inevitable result of our continued consumption of animals and animal products, and the wanton destruction of the ecosystem on which we and other species depend for life.
“One of the most pathetic aspects of human history,” Reinhold Niebuhr wrote, “is that every civilization expresses itself most pretentiously, compounds its partial and universal values most convincingly, and claims immortality for its finite existence at the very moment when the decay which leads to death has already begun.”
Biden’s appointments are drawn almost exclusively from the circles of the Democratic Party and corporate elite, those responsible for the massive social inequality, trade deals, de-industrialization, militarized police, world’s largest prison system, austerity programs that abolished social programs such as welfare, the revived Cold War with Russia, wholesale government surveillance, endless wars in the Middle East and the disenfranchisement and impoverishment of the working class. The Washington Post writes that “about 80 percent of the White House and agency officials he’s announced have the word ‘Obama’ on their résumé from previous White House or Obama campaign jobs.” Bernie Sanders, apparently rebuffed in his efforts to become secretary of labor in the Biden administration, has expressed frustration with the Biden nominations. Rep. Alexandria Ocasio-Cortez was denied a seat by House Democrats on the House Energy and Commerce Committee because of her support for the Green New Deal. The message of the Biden administration to progressives and left-wing populists is very clear – “Drop dead.”
The list of new administration officials includes retired General Lloyd J. Austin III who is being nominated to be secretary of defense. Austin is on the board of Raytheon Technologies and a partner at Pine Island Capital, a firm that invests in defense industries and also includes Antony Blinken, Biden’s nominee to be secretary of state. Blinken, who was deputy national security adviser and deputy secretary of state, is a strong supporter of the apartheid state of Israel. He was one of the architects of the invasion of Afghanistan and Iraq and a proponent of the overthrow of Muammar Gaddafi in Libya, resulting in yet another failed state in the Middle East.
Janet Yellen, former Federal Reserve chair under Barack Obama, is slated to be Treasury Secretary. Yellen as the chair of Bill Clinton’s Council of Economic Advisors (CEA) and later as a member of the board of the Federal Reserve, backed the repeal of Glass-Steagall, which led to the banking crisis of 2008. She supported the North American Free Trade Agreement (NAFTA). She also lobbied for a new statistical metric intended to lower payments to senior citizens on Social Security. Yellen backed “quantitative easing” that provided trillions in virtually no-interest loans to Wall Street, loans used to bail out banks and corporations and engage in massive stock buy-backs while the victims of financial fraud were abandoned.
Former Secretary of State John Kerry is to become a special envoy for climate. Kerry championed the massive expansion of domestic oil and gas production, largely through fracking, and, according to Obama’s memoir, worked doggedly to convince those concerned about the climate crisis to “offer up concessions on subsidies for the nuclear power industry and the opening of additional U.S. coastlines to offshore oil drilling.”
Avril Haines, a former Obama deputy CIA chief, is to become Biden’s director of national intelligence. Haines oversaw Obama’s expanded and murderous drone program overseas and backed Gina Haspel’s nomination to be the head of the CIA, despite Haspels’ direct involvement in the CIA torture program carried out in black sites around the globe. Haines called Haspel “intelligent, compassionate, and fair.” Brian Deese, the executive who was in charge of the “climate portfolio” at BlackRock, which invests heavily in fossil fuels, including coal, and who served as a former Obama economic adviser who advocated austerity measures, has been chosen to run the White House’s economic policy.
Neera Tanden, a former aide to Hillary Clinton, has been picked to be director of the Office of Management and Budget. Tanden, as the head of the Democratic Party’s thinktank, the Center for American Progress, raised millions in dark money from Silicon Valley and Wall Street. Her donors include Bain Capital, Blackstone, Evercore, Walmart and the defense contractor Northrup Grumman. The United Arab Emirates, a close ally of Saudi Arabia in the war in Yemen, also gave the thinktank between $1.5 million and $3 million. She relentlessly ridicules Sanders and his supporters on cable news and social media. She also proposed a plank in the Democratic platform calling for the bombing Iran.
The perpetuation of the deeply unpopular wars and onerous neoliberal policies by the Biden administration will be accompanied by a fevered demonization of Russia, most recently blamed for cyber-attacks. A new Cold War with Russia will be used by the corporate Democrats to discredit domestic and foreign critics and deflect attention from the political stagnation and the corporate pillaging of the country. It will allow MSNBC and The New York Times, which spent two years slogging empty Russiagate conspiracies, to disseminate a daily stream of emotionally charged rumors and shady accusations about Russia. Cable celebrities such as Rachel Maddow will hyperventilate night after night about Russia while ignoring the corruption of the Biden administration. The only reason Russia is not blamed for rigging the election in 2020, as opposed to 2016, by the Democratic Party is because Trump was defeated.
Biden, after his defeat in the Democratic Party Caucus in Nevada by Bernie Sanders, where Sanders got more than twice his vote, immediately played the Russian card, telling CBS News that the “Russians don’t want me to be the nominee, they like Bernie.” Hillary Clinton started this dirty game when she attacked 2016 Green Party presidential candidate Jill Stein as a “Russian asset” and in 2020 leveled the same charge against Rep. Tulsi Gabbard. The Democrats need an enemy, real or fictious, and Silicon Valley and major manufacturers will not allow them to target China.
More of the same means more disaster. If we want to reclaim our open society and save the ecosystem, we must abolish the corporate stranglehold on global economic and political power. If we want to avert zoonotic diseases such as COVID-19, swine flu, avian flu, bovine spongiform encephalopathy (Mad Cow disease), Ebola, and SARS we must stop consuming animals and their bodily secretions. We must abolish factory farming and adopt a vegan diet. And we must keep fossil fuels in the ground.
Razing the rainforest for cattle grazing and vast tracts of farmland devoted to growing monocrops to feed animals destined for human consumption are responsible for up to 91 percent of Amazon rainforest destruction since 1970. The loss of forests is one of the single biggest contributors to climate change. Animal agriculture is the leading cause of ocean dead zones. Oceans could be devoid of fish by 2048. Each minute, 7 million pounds of feces are produced by the animals raised for human food in the US alone. The continued destruction of natural habitat, coupled with the vast factory farms which use 80 percent of the antibiotics in the U.S. and incubate drug-resistant pathogens that spread to human populations, presage new forms of the Black Death.
The belief that we can maintain current levels of consumption, especially of animal products, capitalist expansion, imperial wars, a reliance on fossil fuels and abject subservience to unfettered corporate power, which has solidified the worst income inequality in human history, is not a form of hope but suicidal self-delusion. We are not headed under the policies of the Biden administration and the global ruling elite for the broad sunlit uplands of a new and glorious future, but economic misery, vast climate migrations, waves of new and more virulent pandemics, of which COVID-19 is a mild precursor, along with irreversible ecological systems collapse and frightening forms of societal breakdown, authoritarianism and neofascism.
Global warming is inevitable. It cannot be stopped. At best, it can be slowed. Over the next 50 years the earth will most likely heat up to levels that will make whole parts of the planet uninhabitable. Tens, perhaps hundreds, of millions of people will be displaced. Millions of species will go extinct. Cities on or near a coast, including New York and London, will be submerged.
Oceans absorb much of the excess CO2 and heat from the atmosphere. This absorption is rapidly warming and acidifying ocean waters, resulting in the deoxygenation of the oceans. Each of the earth’s five known mass extinctions was preceded by at least one part of what climate scientists call the “deadly trio” – warming, acidification and deoxygenation of the oceans. The next mass extinction of sea life is already under way, the first in some 55 million years.
This is not defeatism. It is realism. We appear to have bought four years with Biden’s election, but if we do not use it wisely – and there is nothing in the Biden nominations that offer any encouragement – we are merely reconstructing a shabby Potemkin village that will soon be flattened by the gale-force political and environmental hurricanes that are gathering around us.
One of the lessons I learned from covering wars and revolutions as a foreign correspondent is that the political, economic and cultural systems that are erected by any society are very fragile. The façade of power remains in place, as I saw in Eastern Europe during the 1989 revolutions and later in Yugoslavia, long after terminal rot has consumed the foundations. This façade fools a society into thinking the structures of authority remain solid, impervious to collapse. So, when collapse comes, which should have been long predicted, it appears sudden and incomprehensible. The ensuing chaos is disorienting and frightening. The cognitive dissonance between the perception of power and its rapid dissolution feeds self-delusion. It creates, as I witnessed in the former Yugoslavia, what anthropologists call crisis cults, as well as bizarre conspiracy theories, fascism and the embrace of inchoate violence to purge society of the demons blamed for the national debacle. Hatred becomes the highest form of patriotism. The vulnerable are scapegoated. Intellectuals, journalists and scientists rooted in a fact-based world are despised. Ruling elites and ruling structures lose all credibility. This collapse is often a portal to a world of nihilism and blood-drenched fantasy.
After four years of lies, the stoking of racist violence, stunning ineptitude, rampant corruption and an abject failure to cope with a national health crisis, Trump expanded his base by 11 million votes. This should be a huge, flashing red light. Worse, 70 percent of Trump voters, 51 million Americans, believe that “radical Left Democrats” and the deep state rigged the elections through “voter fraud,” including the importation of Venezuelan voting software, illegitimate mail-in ballots and the wholesale destruction of Trump ballots by election officials. One hundred and twenty-six Republican House members joined a lawsuit filed by 18 Republican state attorneys general asking the Supreme Court to overturn Biden’s victory. The vast majority of Republican senators refused to acknowledge the election results following the November vote. Electors from the Electoral College were forced in several states to deliver their votes to state legislatures under armed guard. Some two dozen armed protesters carrying American flags and chanting “Stop the Steal” descended on the home of Democratic Michigan Secretary of State Jocelyn Benson. Seven hundred members of the white nationalist group the Proud Boys took over streets in Washington last weekend to protest the alleged theft of the election, leading to more than three dozen arrests, four stabbings, the vandalizing of four Black churches, and Black Lives Matter banners and signs ripped down and burned.
Trump may be gone soon, but he leaves behind a party that is openly authoritarian, dismissive of democratic norms, an enemy to science and fact-based discourse and which attempted a coup d’état. The next time around they won’t be so disorganized and inept. This hostility to democracy by one of the two ruling parties, supported by millions of Americans, many of whom were betrayed by Biden and the leaders of the Democratic Party, will not dissipate but grow, especially as the hammer of economic dislocation, including the looming evictions of millions of Americans, pummels the country.
The decades-long corporate assault on culture, journalism, education, the arts, universities and critical thinking has left those who speak this truth marginalized and ignored. These Cassandras, locked out of the national debate, are dismissed as unhinged and depressingly apocalyptic. The country is consumed by a mania for hope, which our corporate masters lavishly provide, at the expense of truth. It is this delusional hope that will doom us.
The Austrian writer Stefan Zweig, who with a handful of other writers and artists desperately tried to warn of the suicidal folly of World War I, wrote of what he called “the mental superiority of the defeated.” His anti-war play Jeremiah, based on the Biblical prophet Jeremiah who issued warnings in vain, illustrated that those who face reality, however bitter, are able to endure and rise above it.
“Awaken, doomed city, that thou mayest save thyself,” the prophet cries out in Zweig’s play. “Awaken from your heavy slumbers, heedless ones, lest you be slain in sleep; awaken, for the walls are crumbling, and will crush you; awaken.”
But the warnings from Jeremiah, called “the weeping prophet,” were ignored and ridiculed. He was attacked for demoralizing the people. There were plots against his life. When the Babylonian army captured Jerusalem, Jeremiah, like Julian Assange, was in prison.
“I was always attracted to showing how any form of power can harden a human being’s heart, how victory can bring mental rigidity to whole nations, and to contrasting that with the emotional force of defeat painfully and terribly ploughing through the soul,” Zweig wrote in his memoir, “The World of Yesterday”. “In the middle of war, while others, celebrating triumph too soon, were proving to one another that victory was inevitable, I was plumbing the depths of the catastrophe and looking for a way to emerge from them.”
We cannot use the word hope if we refuse to face the truth. All hope rooted in self-delusion is fantasy. We must lift the filter from our eyes to see the danger before us. We must heed the warnings of our own prophets. We must destroy the centers of power that lure us and our children, like the Pied Piper of Hamelin, to certain doom. The walls, daily, are closing in around us. The radical evil we face is as real under Trump as it will be under Biden. And if this radical evil is not smashed, then the world ahead will be one of torment and mass death.
High homocysteine, vitamin deficiencies more common in cognitively impaired adults
Medical University of Havana (Cuba), December 28 2020.
The October 2020 issue of MEDICC Review published the finding of Cuban researchers of a greater incidence of high homocysteine levels and low levels of several vitamins among older men and women with mild cognitive impairment or Alzheimer disease.
The study included 43 Alzheimer disease patients, 131 individuals with mild cognitive impairment and 250 subjects without cognitive impairment who participated in Cuba’s Aging and Alzheimer Study. Blood samples were analyzed for levels of vitamins A, B1, B2, B12, C and folate, and homocysteine.
Compared to the cognitively healthy group, Alzheimer disease patients had over five times the prevalence of vitamin A deficiency, nearly two times the rate of being deficient in vitamin B1, nearly three times the rate of B2 deficiency, more than double the rate of vitamin B12 deficiency, nearly four times the rate of vitamin C deficiency, three times the rate of folate deficiency, and more than three times the rate of elevated homocysteine levels. Subjects with mild cognitive impairment also had a greater risk of having high homocysteine and deficiencies in vitamins A and B2.
“This is the first study in Cuba to examine vitamin and homocysteine levels in older adults with Alzheimer disease or mild cognitive impairment, and results show a relationship between these nutritional indicators and the cognitive disorders,” authors Yeneisy Lanyau-Domínguez, MS, PhD, and colleagues announced.
They remarked that the availability of antioxidant vitamins is decreased in cognitive disorders due to oxidative stress, which increases the body’s antioxidant requirement. Furthermore, deficient B vitamin levels due to insufficient intake is a cause of high homocysteine in older adults, which can contribute to cognitive impairment and Alzheimer disease through several mechanisms.
“Longitudinal studies are needed to further understand the relationship between different nutritional biomarkers and dementia,” they recommended.
Junk food linked to sleep problems in teens
University of Queensland (Australia), December 23, 2020
Eating too much junk food has been linked with poor sleep quality in teens, a University of Queensland-led study has found.
UQ School of Health and Rehabilitation Sciences researcher Associate Professor Asad Khan said frequent consumption of soft drinks and fast food was strongly associated with sleep disturbance in adolescents around the world.
“This is the first study to examine unhealthy diets and stress-related sleep disturbance on a global scale in high school students from 64 countries,” Dr. Khan said.
“Overall, 7.5 percent of adolescents reported stress-related sleep disturbance, which was more common among females than males.
“Sleep disturbance increased with more frequent consumption of carbonated soft drinks, that often contain caffeine, and/or fast foods, that are traditionally energy-dense and nutrient-poor.
“Teens who drank more than three soft drinks per day had 55 percent higher odds of reporting sleep disturbance than those who only drank one soft drink a day.
“Males who ate fast foods on more than four days per week had 55 percent higher odds of reporting sleep disturbance than those who only ate fast food once a week, while the odds were 49 percent higher in females.
“Frequent consumption of soft drinks more than three times a day, and fast foods more than four days per week, were significantly associated with sleep disturbance in all but low-income countries.”
Data was collected from the World Health Organization’s Global School-based Health Surveys between 2009 and 2016, which included 175,261 students aged 12 to 15 years from 64 low, middle, and high income countries across South East Asia, Africa, parts of South America and the Eastern Mediterranean.
“Teens in high-income countries had the highest association between frequent intake of soft drinks and sleep disturbance,” Dr. Khan said.
“Females in these countries showed the biggest connection between regularly eating fast foods and sleep problems.
“Adolescents in South-Asia showed a high connection between drinking soft drink and sleep disturbance, while those in the Western-Pacific region showed the greatest link between both soft drink and fast food consumption and sleep issues.”
Dr. Khan said the findings were of particular concern as poor quality sleep adversely impacted on adolescent wellbeing and cognitive development.
“The targeting of these unhealthy behaviors needs to be a priority of policies and planning,” he said.
“Strategies need to be customized and tailored across countries or regions to meet their local needs.
“As stress-related sleep disturbance was more common among girls than boys, girls should be a priority target group for associated interventions that could target stress management and sleep quality.
“Creating school environments to limit access to carbonated soft drinks and fast foods, and introducing a sugar tax to lessen the sales of soft drinks may be beneficial.
“Family can also be instrumental in promoting healthy eating as the adoption and maintenance of children’s dietary behaviors are influenced by their familial environments.”
Antimicrobial activity of rosemary leaf extracts and efficacy of ethanol extract against testicular damage caused by 50-Hz electromagnetic field
Minia University (Egypt), May 27, 2020
Rosemary is a restorative plant that has numerous utilizations in traditional medicine. In this investigation, rosemary leaf extracts were examined for their antimicrobial and antioxidant activities. The antimicrobial activity was tested against 8 bacterial strains. The antioxidant feature of rosemary extract on rat testicular tissue after exposure to the electromagnetic field. Sixty adult male albino rats weighing 180-200 g (aged 2 months) were divided into six groups: control group, rosemary group (receiving rosemary extract at a dose of 5 mg/kg b.wt), EMF (2 h) group (exposed to 50 Hz and 5.4 kV per meter of magnetic field for 2 h), EMF (4 h) group (exposed to 50 Hz and 5.4 kV per meter of magnetic field for 4 h), EMF (2 h) + rosemary group (receiving both magnetic field for 2 h and extract), and EMF (4 h) + rosemary group (receiving both magnetic field for 4 h and extract). After 30 days, the rats were sacrificed, and some estimates were determined. Results exhibited that the ethanolic extract of rosemary leaves was active against pathogenic bacteria. Results also demonstrated that exposure to EMF diminished level of male hormones (e.g., follicle stimulating hormone (FSH), testosterone, and luteinizing hormone (LH)) in serum and catalase (CAT) activity remarkably and increased the malondialdehyde (MDA) levels in comparison to the control group. Signs of improvement in the male hormones, CAT activity, and MDA levels were noticed during the treatments with rosemary. Histological results showed that the rosemary extract inhibited the destructive effect of electromagnetic fields on testicular tissue. This research reveals that the ethanolic extract of rosemary has many beneficial effects that can be compelling in supporting individuals living with EMF ecological contamination.
Research conducted at University of North Texas has provided new information about food science
University of North Texas, December 26, 2020
According to news reporting out of Denton, Texas, research stated, “Botanical supplements derived from grapes are functional in animal model systems for the amelioration of neurological conditions, including cognitive impairment. Rats fed with grape extracts accumulate 3’–methyl-quercetin-3–b-d-glucuronide () in their brains, suggesting as a potential therapeutic agent.”
Our news journalists obtained a quote from the research from the University of North Texas, “To develop methods for the synthesis of and the related 4’–methyl-quercetin-7–b-d-glucuronide (), 3–methyl-quercetin-3’–b-d-glucuronide (), and 4’–methyl-quercetin-3’–b-d-glucuronide (), which are not found in the brain, we have evaluated both enzymatic semisynthesis and full chemical synthetic approaches. Biocatalysis by mammalian UDP-glucuronosyltransferases generated multiple glucuronidated products from 4’–methylquercetin, and is not cost-effective. Chemical synthetic methods, on the other hand, provided good results; , and were obtained in six steps at 12, 18, and 30% overall yield, respectively, while was synthesized in five steps at 34% overall yield.”
According to the news editors, the research concluded: “A mechanistic study on the unexpected regioselectivity observed in the quercetin glucuronide synthetic steps is also presented.”
This research has been peer-reviewed.
One psychedelic experience may lessen trauma of racial injustice
Ohio State University, December 28, 2020
A single positive experience on a psychedelic drug may help reduce stress, depression and anxiety symptoms in Black, Indigenous and people of color whose encounters with racism have had lasting harm, a new study suggests.
The participants in the retrospective study reported that their trauma-related symptoms linked to racist acts were lowered in the 30 days after an experience with either psilocybin (Magic Mushrooms), LSD or MDMA (Ecstasy).
“Their experience with psychedelic drugs was so powerful that they could recall and report on changes in symptoms from racial trauma that they had experienced in their lives, and they remembered it having a significant reduction in their mental health problems afterward,” said Alan Davis, co-lead author of the study and an assistant professor of social work at The Ohio State University.
Overall, the study also showed that the more intensely spiritual and insightful the psychedelic experience was, the more significant the recalled decreases in trauma-related symptoms were.
A growing body of research has suggested psychedelics have a place in therapy, especially when administered in a controlled setting. What previous mental health research has generally lacked, Davis noted, is a focus on people of color and on treatment that could specifically address the trauma of chronic exposure to racism.
Davis partnered with co-lead author Monnica Williams, Canada Research Chair in Mental Health Disparities at the University of Ottawa, to conduct the research.
“Currently, there are no empirically supported treatments specifically for racial trauma. This study shows that psychedelics can be an important avenue for healing,” Williams said.
The study is published online in the journal Drugs: Education, Prevention and Policy.
The researchers recruited participants in the United States and Canada using Qualtrics survey research panels, assembling a sample of 313 people who reported they had taken a dose of a psychedelic drug in the past that they believed contributed to “relief from the challenging effects of racial discrimination.” The sample comprised adults who identified as Black, Asian, Hispanic, Native American/Indigenous Canadian, Native Hawaiian and Pacific Islander.
Once enrolled, participants completed questionnaires collecting information on their past experiences with racial trauma, psychedelic use and mental health symptoms, and were asked to recall a memorable psychedelic experience and its short-term and enduring effects. Those experiences had occurred as recently as a few months before the study and as long ago as at least 10 years earlier.
The discrimination they had encountered included unfair treatment by neighbors, teachers and bosses, false accusations of unethical behavior and physical violence. The most commonly reported issues involved feelings of severe anger about being subjected to a racist act and wanting to “tell someone off” for racist behavior, but saying nothing instead.
Researchers asked participants to recall the severity of symptoms of anxiety, depression and stress linked to exposure to racial injustice in the 30 days before and 30 days after the experience with psychedelic drugs. Considering the probability that being subjected to racism is a lifelong problem rather than a single event, the researchers also assessed symptoms characteristic of people suffering from discrimination-related post-traumatic stress disorder (PTSD).
“Not everybody experiences every form of racial trauma, but certainly people of color are experiencing a lot of these different types of discrimination on a regular basis,” said Davis, who also is an adjunct faculty member in the Johns Hopkins University Center for Psychedelic and Consciousness Research. “So in addition to depression and anxiety, we were asking whether participants had symptoms of race-based PTSD.”
Participants were also asked to report on the intensity of three common kinds of experiences people have while under the influence of psychedelic drugs: a mystical, insightful or challenging experience. A mystical experience can feel like a spiritual connection to the divine, an insightful experience increases people’s awareness and understanding about themselvess, and a challenging experience relates to emotional and physical reactions such as anxiety or difficulty breathing.
All participants recalled their anxiety, depression and stress symptoms after the memorable psychedelic experience were lower than they had been before the drug use. The magnitude of the positive effects of the psychedelics influenced their reduction in symptoms.
“What this analysis showed is that a more intense mystical experience and insightful experience, and a less intense challenging experience, is what was related to mental health benefits,” Davis said.
The researchers noted in the paper that the study had limitations because the findings were based on participant recall and the entire sample of recruited research volunteers had reported benefits they associated with their psychedelic experience – meaning it cannot be assumed that psychedelics will help all people of color with racial trauma. Davis and Williams are working on proposals for clinical trials to further investigate the effects of psychedelics on mental health symptoms in specific populations, including Black, Indigenous and people of color.
“This was really the first step in exploring whether people of color are experiencing benefits of psychedelics and, in particular, looking at a relevant feature of their mental health, which is their experience of racial trauma,” Davis said. “This study helps to start that conversation with this emerging treatment paradigm.”
Is there such a thing as an emotional hangover? Researchers find that there is
Rice University, December 26, 2020
Emotional experiences can induce physiological and internal brain states that persist for long periods of time after the emotional events have ended, a team of New York University scientists has found. This study, which appears in the journal Nature Neuroscience, also shows that this emotional “hangover” influences how we attend to and remember future experiences.
“How we remember events is not just a consequence of the external world we experience, but is also strongly influenced by our internal states—and these internal states can persist and color future experiences,” explains Lila Davachi, an associate professor in NYU’s Department of Psychology and Center for Neural Science and senior author of the study.
” ‘Emotion’ is a state of mind,” Davachi continues. “These findings make clear that our cognition is highly influenced by preceding experiences and, specifically, that emotional brain states can persist for long periods of time.”
We have known for quite some time that emotional experiences are better remembered than non-emotional ones. However, in the Nature Neuroscience study, the researchers demonstrated that non-emotional experiences that followed emotional ones were also better remembered on a later memory test.
To do so, subjects viewed a series of scene images that contained emotional content and elicited arousal. Approximately 10 to 30 minutes later, one group then also viewed a series of non-emotional, ordinary scene images. Another group of subjects viewed the non-emotional scenes first followed by the emotional ones. Both physiological arousal, measured in skin conductance, and brain activity, using fMRI, were monitored in both groups of subjects. Six hours later, the subjects were administered a memory test of the images previously viewed.
The results showed that the subjects who were exposed to the emotion-evoking stimuli first had better long-term recall of the neutral images subsequently presented compared to the group who were exposed to the same neutral images first, before the emotional images.
The fMRI results pointed to an explanation for this outcome.
Specifically, these data showed that the brain states associated with emotional experiences carried over for 20 to 30 minutes and influenced the way the subjects processed and remembered future experiences that are not emotional.
“We see that memory for non-emotional experiences is better if they are encountered after an emotional event,” observes Davachi.
How earthing saved one man’s life from EMF sickness
Natural Health 365, December 28, 2020
For Stephen Sinatra, discovering a “new frequency” literally made the difference between life and death, and he credits “earthing” – a movement spearheaded by his father, noted integrative cardiologist Dr. Steve Sinatra – for his dramatic recovery.
Proponents of earthing, or “grounding,” say that the technique of contacting the earth in order to absorb its electromagnetic energy can help re-establish our primal connection, reverse harmful electrical charge in the body – and dramatically improve health and well-being.
What earthing can do for YOU – “I immediately got better…”
Step Sinatra agrees wholeheartedly, maintaining that his former lifestyle on Wall Street exposed him to massive radiation due to electromagnetic frequencies originating from the urban cityscape and his almost-constant cell phone use. Sinatra’s adverse effects from EMFs included nasal problems, coughing, congestion, fatigue, and a troubling sensation that something was “not right.”
These effects grew so severe that the younger Sinatra was hospitalized for forty days. After his father, author of “Earthing: The Next Great Medical Discovery,” suggested earthing – which included a program of walking barefoot and sleeping on sheets woven with silver – Step noted that he could feel a “new frequency” restoring him to health.
However, he suffered a relapse when a WIFI system and several cordless phones were installed in the house in which he was staying – demonstrating for him the difference between” good” and “bad” frequencies, and confirming his determination to continue earthing – while avoiding excessive EMFs.
Modern life physically disconnects us from the earth’s natural energy
Earthing proponents say that we are isolated from earth – and its supply of beneficial negative electrons — by our use of non-conductive materials such as rubber and synthetics in the soles of our shoes, as well as rubber-wheeled cars and bicycles, insulated homes and carpeted floors.
Human beings are already positively charged, and we pick up more voltage when our bodies act as antenna for electrical wiring, WIFI networks, cell phones, TVs and microwaves in the vicinity. This high voltage interferes with the body’s abilities to repair itself during sleep, and can cause unhealthy physiological changes – such as increased cortisol.
How “caveman medicine” can help
Walking barefoot on cool, damp sand, or running shoeless over warm, springy summer grass… there’s a reason that these actions feel so undeniably good – to the point that children, and many adults, intuitively seek out these activities and sensations.
According to Dr. Sinatra, putting bare feet to the ground – what he calls “caveman medicine” – is the cheapest, easiest way to soak up the earth’s negatively-charged electrons and combat destructive free radicals in our bodies. Benefits from “draining the charge,” says Dr. Sinatra, can happen within seconds – and are signaled by the sympathetic nervous system shifting to a more tranquil state.
This relaxed state is accompanied by decreases in muscle tension, changes in EEG brain waves and skin conductance.
Various studies performed by the National Institutes of Health have shown that the simple act of making contact with the earth can impart profound and measurable physiological benefits. And, these benefits seem custom-designed to help ward off the chronic degenerative conditions – including heart disease, diabetes and cancer — that currently plague many aging adults in the United States.
Earthing decreases levels of the stress hormone cortisol, reduces inflammation, enhances immune response, improves glucose regulation, and helps oxygenate the blood while reducing its viscosity – thereby helping to curtail risk of cardiovascular disease.
Earthing also delays the onset of muscle soreness after exercising, reduces the perception of pain, and regulates rates of pulse and respiration. Finally, there is evidence that grounding while sleeping – with the use of specialized grounding sheets – can reduce or eliminate sleep dysfunction.
Watch Dr. Steven Sinatra discuss the benefits of grounding – below:
Small lifestyle changes can add up to better health
In addition to grounding whenever possible, you can make lifestyle changes that reduce your exposure to positively-charged EMFs. Step Sinatra advises techniques such as disabling the WIFI button on the laptop when not in use, leaving cell phones on airplane mode for the majority of the day, using the speaker phone option on cell phones, and using a landline – whenever possible. As leather conducts the energy of the earth, wearing leather-soled shoes is also beneficial.
Many devotees of earthing report that they can physically feel a unique, gentle and life-affirming energy charge released during contact with earth – and they have christened it “vitamin G.” If you feel you have a deficiency of “vitamin G,” the solution – contacting the earth – is free, devoid of side effects, completely natural and simple to employ.
Slash risk of cancer by eating more citrus, according to research
Chinese Academy of Medical Sciences and Harvard Medical School, December 16, 2020
According to the American Cancer Society, 1 in 125 men and 1 in 417 women will be diagnosed with esophageal cancer. While smoking significantly increases the risk of this potentially deadly disease – which has a 5-year survival rate of less than 50 percent – even people who have never smoked can develop it, especially if they drink a lot of alcohol, have a family history, have chronic acid reflux, or have other recognized risk factors.
While esophageal cancer accounts for just 1 percent of all U.S. cancer cases, you still might be wondering how to reduce your cancer risk for this and other conditions. The good news? Protecting your health might involve something as sweet (and delicious) as simply eating more citrus fruit.
Eating citrus fruits may LOWER your risk of cancer by nearly 40 percent
Eating more oranges, clementines, grapefruits, tangerines, and other citruses may “significantly reduce [your] risk of esophageal cancer,” concluded the authors of a meta-analysis published in the peer-reviewed journal Medicine.
To come to this conclusion, the team of researchers assessed data from 19 studies looking at the link between esophageal cancer and intake of citrus fruits. By design, these studies (cohort and case-control) cannot be used to prove causation, but they are able to clarify the correlation between these two factors.
Specifically, it was determined that there was a significantly reduced esophageal cancer risk in people who reported eating more citrus fruits.
The researchers’ statistical analysis revealed an odds ratio of 0.63. Odds ratio is used to measure the relationship between exposure to a given variable (e.g., citrus intake) and a given outcome (esophageal cancer).
In this case, an odds ratio of 0.63 means that the group who reported the highest level of citrus fruit intake had only 63% of the chances of developing esophageal cancer compared to people who report the lowest amount of citrus fruit. In other words, they were about 37 percent LESS likely to develop the deadly disease.
This research is corroborated by plenty of other studies, by the way, including one paper published in Cancer Epidemiology, Biomarkers & Prevention which found that a high intake of green veggies in addition to citrus fruits was also cancer-protective.
Citrus fruit has also been shown to reduce the risk of other types of cancer as well, including cancers of the prostate, breast, and pancreas.
Studies suggest 4 vitamins to lower risk of severe cases of COVID-19
Eastern Virginia Medical School, December 24, 2020
The latest studies show an arsenal in your medicine cabinet could be quite simple, in the form of vitamins.
We get all types of medical tests to evaluate everything from blood pressure to cholesterol.
After dozens of studies have recently shown the importance of Vitamin D when fighting COVID-19, Dr. Peter Osborne with Origins Nutrition Center suggests, you consider a blood test to check your vitamin levels.
“I think that’s probably one of the smartest things that a person could do right now, with an unpredictable role of a relatively unknown illness. What we do know at this point about vitamin therapy, particularly about vitamin D, a new study has come out and a new analysis has come out on what we know about vitamin D and COVID. So far, here’s what we know: people with low vitamin D who get COVID have a greater tendency toward dying, have a greater tendency toward hyper-inflammation in the cytokine storm that comes with COVID, and have a greater tendency toward getting on ventilators, which are very bad because ventilators don’t work very well for COVID. When a person’s on a ventilator with COVID it’s not a good thing. So, the outcomes aren’t great, so if we can keep people off of ventilators and we can keep their immune system supported really well with nutrition, that ideally that makes the most sense,” explains Dr. Osborne.
He also says the most recent studies show that nine out of 10 COVID-19 deaths could be prevented if people had adequate Vitamin D levels.
Vitamin D in our bodies often goes down in the wintertime, because fewer people are outside and not soaking it up from the sun. You need at least 20 minutes of sunlight every day to get an adequate amount, which is why a supplement is often needed to get to a healthy level.
Some hospitals around the country are even using vitamins as a treatment for COVID-19, not just prevention.
“A lot of doctors are now learning this and coming out and saying it! The East Virginia School of Medicine actually has a COVID protocol that includes Vitamin D. So if you’re a patient who gets hospitalized for COVID, they’re automatically putting you on between 20,000 and 60,000 units of Vitamin D. This is part of their standard of care protocol in that hospital system,” says Dr. Osborne.
Dr. Osborne believes Vitamin D is one of the most simple and affordable ways to help you stay healthy.
“Vitamin D is very inexpensive. You can buy it at the local nutrition store, and it might just save your life, should you get sick. With vitamin D, there’s a therapy that can be done that I recommend, and it’s 1000 international units (IU) of vitamin D per pound. So if you’re 100 pounds, you would take 100,000 international units of vitamin D for three days. After that, you don’t have to keep taking those higher doses, but three days of high dose vitamin D will elevate your serum vitamin D levels to adequate levels,” states Dr. Osborne.
If you have a condition called sarcoidosis ? Dr. Osborne says this many vitamins would not be safe for you.
Along with following the CDC health guidelines, he encourages everyone to think of boosting their immune systems as a four-pronged approach, using four different supplements.
Number 1: Vitamin D, get your levels up, and you can also ask your doctor to test your levels, a very easy blood test.
Number 2: Vitamin C, we know it’s working well. There have been some studies on COVID where vitamin C has shown to have very good benefits in the outcome of an illness.
Number 3: Zinc stops viral replication multiple ways, so it prevents the virus from hijacking your DNA, prevents the virus from replicating. It also prevents the virus from entering the cell, so zinc is very important right now.
Number 4: Quercetin, which is what’s called a natural bioflavonoid. Quercetin opens up the cells in your body so that zinc can get inside your cells, where it works. So think of quercetin as the key. Think of zinc as the repairman, that is allowed into the house, so-to-speak,” says Dr. Osborne.
Some hospitals are treating COVID with all four of those supplements. Dr. Osborne says these are the ones to focus on to cover your bases, nutritionally. There are only a few dietary sources of vitamin D like cod liver oil, fatty fish, and mushrooms that could help you reach the recommended daily allowance, but you would have to eat a lot of it.
The Secret to Longevity? 4-Minute Bursts of Intense Exercise May Help
Including high-intensity training in your workouts provided better protection against premature death than moderate workouts alone
Norwegian University of Science and Technology, December 22, 2020
If you increase your heart rate, will your life span follow?
That possibility is at the heart of an ambitious new study of exercise and mortality. The study, one of the largest and longest-term experimental examinations to date of exercise and mortality, shows that older men and women who exercise in almost any fashion are relatively unlikely to die prematurely. But if some of that exercise is intense, the study also finds, the risk of early mortality declines even more, and the quality of people’s lives climbs.
Scientists have known for some time, of course, that active people tend also to be long-lived people. According to multiple past studies, regular exercise is strongly associated with greater longevity, even if the exercise amounts to only a few minutes a week.
But almost all of these studies have been observational, meaning they looked at people’s lives at a moment in time, determined how much they moved at that point, and later checked to see whether and when they passed away. Such studies can pinpoint associations between exercise and life spans, but they cannot prove that moving actually causes people to live longer, only that activity and longevity are linked.
To find out if exercise directly affects life spans, researchers would have to enroll volunteers in long-term, randomized controlled trials, with some people exercising, while others work out differently or not at all. The researchers then would have to follow all of these people for years, until a sufficiently large number died to allow for statistical comparisons of the groups.
Those obstacles did not deter a group of exercise scientists at the Norwegian University of Science and Technology in Trondheim, Norway, however. With colleagues from other institutions, they had been studying the impacts of various types of exercise on heart disease and fitness and felt the obvious next step was to look at longevity. So, almost 10 years ago, they began planning the study that would be published in October in The BMJ.
Their first step was to invite every septuagenarian in Trondheim to participate. Mortality studies involving older people are the most likely to return useful data, the scientists reasoned, since, realistically, there will be more deaths among the elderly than the young, making it possible to compare differences in longevity between study groups.
More than 1,500 of the Norwegian men and women accepted. These volunteers were, in general, healthier than most 70-year-olds. Some had heart disease, cancer or other conditions, but most regularly walked or otherwise remained active. Few were obese. All agreed to start and continue to exercise more regularly during the upcoming five years.
The scientists tested everyone’s current aerobic fitness as well as their subjective feelings about the quality of their lives and then randomly assigned them to one of three groups. The first, as a control, agreed to follow standard activity guidelines and walk or otherwise remain in motion for half an hour most days. (The scientists did not feel they could ethically ask their control group to be sedentary for five years.)
Another group began exercising moderately for longer sessions of 50 minutes twice a week. And the third group started a program of twice-weekly high-intensity interval training, or H.I.I.T., during which they cycled or jogged at a strenuous pace for four minutes, followed by four minutes of rest, with that sequence repeated four times.
Almost everyone kept up their assigned exercise routines for five years, an eternity in science, returning periodically to the lab for check-ins, tests and supervised group workouts. During that time, the scientists noted that quite a few of the participants in the control had dabbled with interval-training classes at local gyms, on their own initiative and apparently for fun. The other groups did not alter their routines.
After five years, the researchers checked death registries and found that about 4.6 percent of all of the original volunteers had passed away during the study, a lower number than in the wider Norwegian population of 70-year-olds, indicating these active older people were, on the whole, living longer than others of their age.
But they also found interesting, if slight, distinctions between the groups. The men and women in the high-intensity-intervals group were about 2 percent less likely to have died than those in the control group, and 3 percent less likely to die than anyone in the longer, moderate-exercise group. People in the moderate group were, in fact, more likely to have passed away than people in the control group.
The men and women in the interval group also were more fit now and reported greater gains in their quality of life than the other volunteers.
In essence, says Dorthe Stensvold, a researcher at the Norwegian University of Science and Technology who led the new study, intense training — which was part of the routines of both the interval and control groups — provided slightly better protection against premature death than moderate workouts alone.
Of course, exercise was not a panacea, she adds. Some people still sickened and died, whatever their workout program. (No one died while exercising.) This study also focused on Norwegians, who tend to be preternaturally healthy, and most of us, perhaps regrettably, are not Norwegians. We also may not yet be in our 70s.
But Dr. Stensvold believes the study’s message can be broadly applicable to almost all of us. “We should try to include some exercise with high intensity,” she says. “Intervals are safe and feasible for most people. And adding life to years, not only years to life, is an important aspect of healthy aging, and the higher fitness and health-related quality of life from H.I.I.T. in this study is an important finding.”
In shaky times, focus on past successes, if overly anxious, depressed
Emotionally resilient people better at exercising sound judgment when things get chaotic
University of California at Berkeley, December 23, 2020
The more chaotic things get, the harder it is for people with clinical anxiety and/or depression to make sound decisions and to learn from their mistakes. On a positive note, overly anxious and depressed people’s judgment can improve if they focus on what they get right, instead of what they get wrong, suggests a new UC Berkeley study.
The findings, published today, Dec. 22, in the journal eLife, are particularly salient in the face of a COVID-19 surge that demands tactical and agile thinking to avoid illness and even death.
UC Berkeley researchers tested the probabilistic decision-making skills of more than 300 adults, including people with major depressive disorder and generalized anxiety disorder. In probabilistic decision making, people, often without being aware of it, use the positive or negative results of their previous actions to inform their current decisions.
The researchers found that the study participants whose symptoms intersect with both anxiety and depression — such as worrying a lot, feeling unmotivated or not feeling good about themselves or about the future — had the most trouble adjusting to changes when performing a computerized task that simulated a volatile or rapidly changing environment.
Conversely, emotionally resilient study participants, with few, if any, symptoms of anxiety and depression, learned more quickly to adjust to changing conditions based on the actions they had previously taken to achieve the best available outcomes.
“When everything keeps changing rapidly, and you get a bad outcome from a decision you make, you might fixate on what you did wrong, which is often the case with clinically anxious or depressed people,” said study senior author Sonia Bishop, a professor of neuroscience at UC Berkeley. “Conversely, emotionally resilient people tend to focus on what gave them a good outcome, and in many real-world situations that might be key to learning to make good decisions.”
That doesn’t mean people with clinical anxiety and depression are doomed to a life of bad decisions, Bishop said. For example, individualized treatments, such as cognitive behavior therapy, could improve both decision-making skills and confidence by focusing on past successes, instead of failures, she noted.
The study expands on Bishop’s 2015 study, which found that people with high levels of anxiety made more mistakes when tasked with making decisions during computerized assignments that simulated both stable and rapidly changing environments. Conversely, non-anxious study participants quickly adjusted to the changing patterns in the task.
For this latest study, Bishop and her team looked at whether people with depression would also struggle to make sound decisions in volatile environments and whether this would hold true when challenged with different versions of the task.
“We wanted to see if this weakness was unique to people with anxiety, or if it also presented in people with depression, which often goes hand in hand with anxiety,” Bishop said. “We also sought to find out if the problem was a general one or specific to learning about potential reward or potential threat.
The first experiment involved 86 men and women aged between 18 and 50. The group included people diagnosed with generalized anxiety disorder, major depressive disorder, people who showed symptoms of anxiety or depression, but no formal diagnoses of these disorders, and people with neither anxiety nor depression.
In a laboratory setting, study participants played a game on a computer screen in which they repeatedly chose between two shapes — a circle and a square. One shape, if selected, would deliver a mild to moderate electrical shock, and another would deliver a monetary prize. The probability of a shape delivering a reward or a shock was predictable at some points in the task, and volatile in others. Participants with high levels of symptoms common to depression and anxiety had trouble keeping pace with these changes.
In the second experiment, 147 U.S. adults, with varying degrees of anxiety and depression were recruited via Amazon’s Mechanical Turk crowdsourcing marketplace and given the same task remotely. This time, they chose between red and yellow squares on a screen. They still received monetary rewards, but instead of being penalized with electric shocks, they lost money.
The results echoed those of the in-laboratory outcomes. Overall, having symptoms common to both anxiety and depression predicted who would struggle most with making sound decisions in the face of changing circumstances, regardless of whether they were rewarded or punished for getting things right or wrong, compared to their emotionally resilient counterparts.
“We found that people who are emotionally resilient are good at latching on to the best course of action when the world is changing fast,” Bishop said “People with anxiety and depression, on the other hand, are less able to adapt to these changes. Our results suggest they might benefit from cognitive therapies that redirect their attention to positive, rather than negative, outcomes.”
Exposure to These Metals May Alter Pregnancy Hormones
Exposure to metals such as nickel, arsenic, cobalt, and lead may disrupt hormones during pregnancy, according to new research
Rutgers University, December 23, 2020
Exposure to metals has been associated with problems at birth such as preterm birth and low birth weight in babies, and preeclampsia in women. However, little is known about how metals exposure can lead to such problems. The new research shows that some metals may disrupt the endocrine system, which is responsible for regulating our body’s hormones. These disruptions may contribute to children’s later health and disease risk.
“A delicate hormonal balance orchestrates pregnancy from conception to delivery and perturbations of this balance may negatively impact both mother and fetus,” says lead author Zorimar Rivera-Núnez, an assistant professor in the department of biostatistics and epidemiology at the Rutgers University School of Public Health.
The researchers analyzed blood and urine samples from 815 women enrolled in the Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) study. Initiated in 2010, PROTECT is an ongoing prospective birth cohort studying environmental exposures in pregnant women and their children around the northern karst zone, which includes urban and mountainous rural areas of Puerto Rico.
They found that metals can act as endocrine disruptors by altering prenatal hormone concentrations during pregnancy. This disruption may depend on when in the pregnancy exposure happens.
Prenatal exposure to metals can have enormous consequences even beyond health at birth. Alterations in sex-steroid hormones during pregnancy have been associated with inadequate fetal growth, which leads to low birthweight. Birth size is strongly associated with a child’s growth and risk of chronic diseases, including obesity and breast cancer.
“Puerto Rico has one of the highest rates of Superfund sites of any of the US jurisdictions with 18 active sites, which can contribute to the higher rates of exposure to toxic metals,” says Rivera-Núnez.
Among pregnant women, metal exposure is higher in those living in Puerto Rico than in those in the continental United States.
“This is important because, compared to the US overall, women in Puerto Rico have significantly higher rates of preterm birth [nearly 12%] and other adverse birth outcomes. Additionally, exposure to environmental pollution is exacerbated by extreme weather events, such as hurricanes, droughts, and flooding, which may result in elevated exposures to Superfund sites,” she adds.
According to the study authors, future research should investigate how changes in markers of endocrine function affect birth and other health outcomes. Future studies also should look at essential metals in relation to maternal and fetal health, and metals as mixtures in relation to markers of endocrine function.
The study appears in the journal Environment International.
High antioxidant fruits top list for lung protection
Johns Hopkins Bloomberg School of Public Health, December 27 2020.
The December issue of the European Respiratory Journal published the results of a study that found protective effects for tomatoes and other high antioxidant fruits against the decline in lung function that can occur during aging. “In the present study, we sought to investigate whether a higher intake of dietary sources of antioxidants in middle-aged European adults could attenuate ageing-related lung function decline over 10 years,” explained lead researcher Vanessa Garcia-Larsen of Johns Hopkins Bloomberg School of Public Health and her associates.
The current investigation, which is part of the Ageing for Lungs in European Cohorts study, included 680 adults that participated in the European Community Respiratory Health Survey.
A high intake of fruit and apples was associated with a decrease in the decline in forced expiratory volume in one second (FEV1) over ten years of follow up. Consuming more apples, bananas, tomatoes, herb tea and vitamin C was associated with a reduction in the decline of forced vital capacity (FVC), another measure of lung function. Further statistical analysis found significance for tomato intake as protective against FVC decline. When smokers, nonsmokers and ex-smokers were separately considered, higher apple, banana and tomato intake were associated with a reduction in FVC decline in ex-smokers.
“This study shows that diet might help repair lung damage in people who have stopped smoking,” Dr Garcia-Larsen stated. “It also suggests that a diet rich in fruits can slow down the lung’s natural aging process even if you have never smoked. The findings support the need for dietary recommendations, especially for people at risk of developing respiratory diseases such as COPD.”
Supplement Recently Discovered To Help PTSD Better Than Ssris
University of South Carolina, December 23, 2020
A new study coming out of the University of South Carolina shows extremely promising results for a new treatment for PTSD and substance abuse.
Although the new treatment is being misbranded as a pharmaceutical intervention – the substance being used is actually quite natural and has been known to many in the natural health world as a very beneficial supplement for quite some time.
N-acetylcysteine (NAC) when combined with group Cognitive Behavioral Therapy (CBT) was demonstrated in the study to be more effective than CBT alone as well as more effective than FDA-approved SSRIs at treated PTSD cravings and depression.
The trial conducted by Dr. Peter Kalivas, Professor and Chair of the Department of Neuroscience at the Medical University of South Carolina and Dr. Sudie Back, Professor in the Department of Psychiatry and Behavioral Sciences at MUSC involved a group of Viet Nam veterans suffering from PTSD.
Veterans in the group treated with NAC showed a 46% reduction in PTSD symptoms.
A placebo group showed a 25% reduction.
The percentage scale was measured by the clinical administered PTSD scale (CAPS) – a scale in which the threshold score is 50.
“As a group, the NAC-treated veterans were below diagnostic level for PTSD at the end of treatment,” said Back. “For PTSD, these are some of the best outcomes we have seen in the literature for a medication.”
According to the press release,
Craving and depression were also reduced in the NAC-treated group. The amount of craving was reduced by 81% and the frequency of craving by 71% in the NAC group, compared with 32% and 29% in the placebo group. “Craving is a key component of substance use in relapse,” said Back.
“If you have a medication that can really reduce craving, that will go a long way to helping people stay clean and sober.” Depression, gauged using the Beck Depression Inventory, was reduced 48% in the NAC group vs. 15% in the placebo group.
The researchers, however, were quick to point out that NAC alone should not be used as a substitute for traditional behavioral treatment but that it might be seen as an adjunct, enhancing therapy.
Krill oil extract inhibits the migration of human colorectal cancer cells
Victoria University (New Zealand), December 18, 2020
According to news reporting from Victoria University , research stated, “The currently available treatments for colorectal cancer (CRC) are often associated with serious side-effects. Therefore, the development of a novel nutraceutical agent may provide an alternative complementary therapy for CRC.”
The news editors obtained a quote from the research from Victoria University: “Overexpression of the epidermal growth factor receptor (EGFR) associates with a range of cancers while downregulation of EGFR signalling can inhibit cancer growth. Our previous studies have shown that the free fatty acid extract (FFAE) of krill oil exhibits anti-proliferative and pro-apoptotic properties. This study determines the effects of krill oil extract on the migration of human CRC cells, and its potential role in modulating EGFR signalling pathway and the expression of programmed death ligand 1 (PD-L1). Human CRC cells, DLD-1 and HT-29 were treated with FFAE of KO at 0.03 and 0.12 mL/100 mL for 8 or 24 h. Cell migration was determined by Boyden chamber migration assay. The expression of EGFR, phosphorylated EGFR (pEGFR), protein kinase B (AKT), phosphorylated AKT (pAKT), extracellular signal regulated kinase (ERK1/2), phosphorylated ERK1/2 (pERK1/2) as well as PD-L1 were assessed by western blotting and immunohistochemistry. The FFAE of krill oil significantly inhibited cell migration compared to ethanol-treated (vehicle control) cells (P < 0.01 to P < 0.001). At the molecular level, krill oil extract reduced the expression of EGFR, pEGFR (P < 0.001 for both) and their downstream signalling, pERK1/2 and pAKT (P < 0.01 to P < 0.001) without altering total ERK 1/2 and AKT levels. In addition, the expression of PD-L1 was reduced by 67 to 72% (P < 0.001) following the treatment with krill oil extract.”
According to the news editors, the research concluded: “This study has demonstrated that krill oil may be a potential therapeutic/adjunctive agent for CRC attributed to its anti-migratory effects.. The potential anti-cancer properties of krill oil are likely to be associated with the downregulation of EGFR, pEGFR and their downstream pERK/ERK1/2 and pAKT/AKT signalling pathways along with the downregulation of PD-L1.”
Increased meat consumption associated with symptoms of childhood asthma
Mt Sinai School of Medicine, December 22, 2020
Substances present in cooked meats are associated with increased wheezing in children, Mount Sinai researchers report. Their study, published in Thorax, highlights pro-inflammatory compounds called advanced glycation end-products (AGEs) as an example of early dietary risk factors that may have broad clinical and public health implications for the prevention of inflammatory airway disease.
Asthma prevalence among children in the United States has risen over the last few decades. Researchers found that dietary habits established earlier in life may be associated with wheezing and potentially the future development of asthma.
Researchers examined 4,388 children between 2 and 17 years old from the 2003-2006 National Health and Nutrition Examination Survey (NHANES), a program of the National Center for Health Statistics, which is part of the U.S. Centers for Disease Control and Prevention. It is designed to evaluate the health and nutritional status of adults and children in the United States through interviews and physical examinations.
The researchers used NHANES survey data to evaluate associations between dietary AGE and meat consumption frequencies, and respiratory symptoms. They found that higher AGE intake was significantly associated with increased odds of wheezing, importantly including wheezing that disrupted sleep and exercise, and that required prescription medication. Similarly, higher intake of non-seafood meats was associated with wheeze-disrupted sleep and wheezing that required prescription medication.
“We found that higher consumption of dietary AGEs, which are largely derived from intake of non-seafood meats, was associated with increased risk of wheezing in children, regardless of overall diet quality or an established diagnosis of asthma,” said Jing Gennie Wang, MD, lead author of the study, and a former fellow in Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai.
“Research identifying dietary factors that influence respiratory symptoms in children is important, as these risks are potentially modifiable and can help guide health recommendations. Our findings will hopefully inform future longitudinal studies to further investigate whether these specific dietary components play a role in childhood airways disease such as asthma,” said Sonali Bose, MD, senior author, and Assistant Professor of Pulmonary, Critical Care and Sleep Medicine and Pediatrics at Icahn School of Medicine at Mount Sinai.
Nanoplastics Alter Intestinal Microbiome And Threaten Human Health
University of Barcelona (Spain), December 22, 2020
A revised study led by the Universitat Autónoma de Barcelona (UAB), the CREAF and the Centre for Environmental and Marine Studies (CESAM) at the University of Aviero, Portugal, and published in the journal Science Bulletin, verifies that the nanoplastics affect the composition and diversity of our intestinal microbiome and that this can cause damage to our health. This effect can be seen in both vertebrates and invertebrates, and has been proved in situations in which the exposure is widespread and prolonged. Additionally, with alteration of the gut microbiome come alterations in the immune, endocrine and nervous system and therefore, although not enough is known about the specific physiological mechanisms, the study alerts that stress to the gut microbiome could alter the health of humans.
The health effects of being exposed to nanoplastics was traditionally evaluated in aquatic animals such as molluscs, crustaceans and fish. Recent in vitro analyzes, using cell cultures of fish and mammals, has allowed scientists to analyze the changes in gene expression associated with the presence of nanoplastics from a toxicological viewpoint. The majority of neurological, endocrine and immunological tracts in these vertebrates are very similar to those of humans, and therefore authors warn that some of the effects observed in these models could also be applied to humans. Understanding and analyzing the process through which these plastic fragments penetrate the organism and harm it is fundamental, as is determining precisely the amount and typology of nanoplastics polluting the environment. For this reason, researchers highlight not only the need to further study the specific mechanisms and effects on human cell models, but also unify analysis methodologies in order to conduct correct measurements of the quantity of nanoplastics present in different ecosystems.
Mariana Teles, researcher at the UAB, in collaboration with other researchers such as Josep Peñuelas, CSIC lecturer at the CREAF, comments that “this article does not aim to raise the alarm, but it does seek to warn about the fact that plastic can be found in almost everything surrounding us, it does not disintegrate and we are constantly exposed to it. At the moment, we can only speculate on the long-term effects this can have on human health, although we already have evidence in several studies describing hormonal and immune alterations in fish exposed to nanoplastics, and which could be applied to humans.”
Invasive and Toxic
The study presents the main environmental sources through which nanoplastics enter the human body and summarizes how they are able to penetrate the body: by ingesting them, occasionally inhaling them, and very rarely by being in contact with human skin.
Once they are ingested, up to 90% of the plastic fragments that reach the intestine are excreted. However, one part is fragmented into nanoplastics which are capable, due to their small size and molecular properties, to penetrate the cells and cause harmful effects. The study establishes that alterations in food absorption have been described, as well as inflammatory reactions in the intestinal walls, changes in the composition and functioning of the gut microbiome, effects on the body’s metabolism and ability to produce, and lastly, alterations in immune responses. The article alerts about the possibility of a long-term exposure to plastic, accumulated throughout generations, could give way to unpredictable changes even in the very genome, as has been observed in some animal models.
The team in which Mariana Teles (Evolutive Immunology Group, IBB-UAB) is member also recently published a second article analyzing the effects of nanoplastics in fish. The study, which is the result of Irene Brandts’ Ph.D. thesis directed by Nerea Roher, was published in Environmental Science: Nano and analyzes the consequences of being exposed to nanoplastics to the immune system of a zebrafish (a small tropical fish widely used as a model organism for research). The scientists conclude that the nanoplastics can accumulate both in the cells and in the embryos of the zebrafish, additionally causing changes in the levels of genes relevant to the correct functioning of the animal’s immune system. Despite this fact, the capacity of zebrafish embryos to survive a bacterial infection was not affected by the exposure to nanoplastics. The team of researchers nonetheless defend the need to continue research in this field, given that the presence of microplastics and nanoplastics in our ecosystems is an extremely crucial environmental issue which needs answers in order to understand how far-reaching any possible consequences may be.
Responsible usage
The review study acknowledges that different techniques are being tested to eliminate nanoplastics from the water, such as filtration, centrifugation and flocculation of wastewater, and the treatment of rainwater. Although the results are promising, they are limited to treating larger particles of plastics, and therefore until date no effective solution has been found for the elimination of nanoplastics from the environment.
“To solve this problem of plastic pollution, human routines must change and policies should be based on informed decisions on the known risks and available alternatives. Individual actions such as the use of more environmentally-friendly products and an increase in recycling indexes are important,” Mariana Teles comments.
“The authorities can promote these pro-environmental actions through economic stimuli, such as tax benefits for reusing plastic as industrial raw material, as well as bottle deposit schemes for consumers,” researchers recommend.
Cocoa compound linked to some cardiovascular biomarker improvements
Brown University, December 14, 2020
To the tantalizing delight of chocolate lovers everywhere, a number of recent studies employing various methods have suggested that compounds in cocoa called flavanols could benefit cardiovascular health. Now a systematic review and meta-analysis of 19 randomized controlled trials (RCTs) of cocoa consumption reveals some further pieces of supporting evidence.
The meta-analysis in the Journal of Nutrition, an assessment of the combined evidence from all 19 RCTs, focused on whether consumption of flavanol-rich cocoa products was associated with improvements in specific circulating biomarkers of cardiometabolic health as compared to consuming placebos with negligible cocoa flavanol content. In all, 1,139 volunteers were involved in these trials.
“Our meta-analysis of RCTs characterizes how cocoa flavanols affect cardiometabolic biomarkers, providing guidance in designing large, definitive prevention trials against diabetes and cardiovascular disease in future work,” said corresponding author Dr. Simin Liu, professor and director of the Center for Global Cardiometabolic Health at Brown University who worked with epidemiology graduate student and lead author Xiaochen Lin. “We found that cocoa flavanol intake may reduce dyslipidemia (elevated triglycerides), insulin resistance and systemic inflammation, which are all major subclinical risk factors for cardiometabolic diseases.”
Liu noted some limitations in the trials. All studies were small and of short duration, not all of the biomarkers tracked in these studies changed for the better, and none of the studies were designed to test directly whether cocoa flavanol consumption leads to reduced cases of heart attacks or type 2 diabetes.
But taking into account some of these heterogeneities across studies, the team’s meta-analysis summarizing data from 19 trials found potential beneficial effects of flavanol-rich cocoa on cardiometabolic health. There were small-to-modest but statistically significant improvements among those who ate flavanol-rich cocoa product vs. those who did not.
The greatest effects were seen among trial volunteers who ate between 200 and 600 milligrams of flavanols a day (based on their cocoa consumption). They saw significant declines in blood glucose and insulin, as well as another indicator of insulin resistance called HOMA-IR. They also saw an increase in HDL, or “good,” cholesterol. Those consuming higher doses saw some of the insulin resistance benefits and a drop in triglycerides, but not a significant increase in HDL. Those with lower doses of flavanols only saw a significant HDL benefit.
In general, Lin said, where there were benefits they were evident for both women and men and didn’t depend on what physical form the flavanol-rich cocoa product was consumed in —dark chocolate vs. a beverage, for example.
“The treatment groups of the trials included in our meta-analysis are primarily dark chocolate—a few were using cocoa powder-based beverages,” Lin said. “Therefore, the findings from the current study apparently shouldn’t be generalized to different sorts of chocolate candies or white chocolates, of which the content of sugar/food additives could be substantially higher than that of the dark chocolate.”
The authors therefore concluded, “Our study highlights the urgent need for large, long-term RCTs that improve our understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.”
Remnant cholesterol more strongly associated with cardiovascular events than LDL in study
Hospital del Mar Medical Research Institute (Spain), December 18 2020.
The December 8, 2020 issue of the Journal of the American College of Cardiology published the results of a study that examined the association of the occurrence of major cardiovascular events with triglyceride levels and cholesterol fractions in older men and women at risk of cardiovascular disease. The investigation uncovered a greater association of these events with remnant cholesterol [which is composed of very low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL)] than with low-density lipoprotein (LDL) cholesterol, which is believed to be the primary driver of cardiovascular disease. Triglyceride levels were also found to have a significant association with the development of major cardiovascular events.
The investigation included 6,901 participants in the PREDIMED (Prevención con Dieta Mediterránea) trial, which compared the effects of a Mediterranean diet enhanced with extra-virgin olive oil or nuts to a control diet for the prevention of cardiovascular disease among at-risk individuals. Blood samples collected upon enrollment beginning in 2003 were analyzed for total, high-density lipoprotein (HDL) and LDL cholesterol, triglycerides and other factors. Remnant cholesterol was calculated by subtracting LDL and HDL cholesterol from total cholesterol levels.
Major adverse cardiovascular events occurred among 263 participants during the follow-up period, which concluded at the end of 2010. While LDL and HDL cholesterol were not significantly associated with major adverse cardiovascular events, each 10 milligram per deciliter increase in triglycerides, non-HDL cholesterol and remnant cholesterol was associated with 4%, 5% and 21% respective increases in risk.
In an accompanying editorial, John Burnett, Amanda Hooper and Robert Hegele predicted that “One could envision a future where in addition to the routine lipid profile, newer analytes such as remnant cholesterol as well as lipoprotein(a) and apo B are reported to improve prognostication and help guide preventive treatments.”
Vitamin C deficiency linked to pneumonia
University of Helsinki, December 23, 2020
For over 70 years, forward-thinking physicians have noted the association between vitamin C deficiency and pneumonia – a serious health condition that claims over 50,000 lives a year. For example, in medical literature written as early as 1936, physicians credited the vitamin with “favorably influencing” outcomes for pneumonia patients.
However, the attitude of Western medicine towards high-dose vitamins has deteriorated since the 1970’s – when poorly designed, low-dosage studies appeared to show a lack of vitamin C benefits for respiratory conditions. Fortunately, a surge of recent studies and reviews are shedding new light on the preventive and therapeutic powers of vitamin C against pneumonia – and other respiratory diseases.
Mild and severe vitamin C deficiencies alike are linked with an increased risk of infectious disease
In the 1930’s, scientists made a connection between scurvy – severe vitamin C deficiency – and pneumonia. Not only is pneumonia one of the most frequent complications of scurvy, but it is a common prevailing cause of death.
People in good health have vitamin C blood concentrations of about 70 micromoles per liter. Moderate vitamin C deficiencies can occur at around 23 micromoles per liter, while severe deficiencies – and risk of scurvy – appear at concentrations under 11 micromoles/liter.
Startling new research shows that 14 percent of males and 10 percent of females in the US have vitamin C levels below 11 micromoles/liter – the clinical threshold for severe deficiency.
Not only are severe vitamin C deficiencies strongly linked with pneumonia, but milder, or “marginal,” vitamin C deficiencies are also associated with increased risk and severity of infections.
Avoiding vitamin C deficiencies can dramatically slash pneumonia risk
In a review published in Nutrients, Dr. Harri Hemila of the University of Helsinki noted that three different controlled trials found that vitamin C significantly protected against pneumonia – reducing risk by up to 80 percent.
Dr. Hemila also reported that two separate studies had found a treatment benefit of vitamin C for pneumonia patients.
In one study involving pneumonia patients, researchers found that a dosage of vitamin C ranging from 500 to 1600 milligrams a day cut hospital duration by a third. The patients also experienced benefits that included normalization of chest X-rays, temperature, and ESR, or erythrocyte sedimentation rate.
According to Dr. Hemila, 148 animal studies show that vitamin C may alleviate or prevent infections caused by bacteria, viruses and fungi – including tuberculosis, strep infections, diphtheria and Candida albicans.
In addition, the regular administration of this essential nutrient can shortens the duration of colds.
Vitamin C levels decline with illness – making supplementation a must
Researchers have found that white blood cells have vitamin C levels up to ten times higher than those of blood plasma, indicating a functional role in the immune system. In fact, they have discovered that cells have active vitamin C transporter molecules in their membranes to help the vitamin gain access.
Scientists believe that vitamin C stimulates the immune system and promotes the functions of disease-fighting phagocytes. But the increased need for vitamin C in times of illness can create shortages in the body that must be corrected.
For this reason, integrative healthcare providers have long insisted that intake of vitamin C should be drastically raised when illness is present. In addition, the nutrient’s antioxidant properties can help curtail the oxidative stress that is created by the immune system in response to pathogens.
Top Five Traditional, Fermented Anti-Aging Foods
GreenMedInfo, December 17th 2020
Want a simple way to boost your brain power, heart health, digestion, disease resistance and energy level? If that all sounds too good to be true, it’s time you got acquainted with the top five traditional, fermented antiaging foods
If you are interested in optimizing and maintaining your health and vitality, eating a nutrient-dense diet is a critical piece to the puzzle. Consuming foods with high levels of essential vitamins, minerals and micronutrients provides cells with the building blocks for regeneration and disease prevention and is essential to long-term wellness.
One of the most potent sources of nutrition, bite-for-bite, are fermented foods. An ancient method of food preservation, fermentation is a natural process in which microbes, such as bacteria or yeast, convert sugars into acids or alcohol under anaerobic conditions. Fermentation produces “good” bacteria called probiotics, which confer a wealth of benefits to intestinal flora when consumed, enhancing the health of your gut microbiome and boosting your immune system.
Is Fermented Food the REAL Fountain of Youth?
With nearly 35% of the U.S. population aged 45 and older,[i] medical researchers are on the hunt for a real fountain of youth. Thanks to the enzymatic boost provided by living microbes in fermented foods, the secret to lifelong vitality may lie in adding these nutritional powerhouses to your dinner plate. The scientifically backed health benefits of eating probiotic-rich fermented foods include:
- Improved digestion[ii]
- Boosted immunity[iii]
- Enhanced weight loss[iv]
- Treatment and prevention of gastrointestinal diseases[v]
- Faster healing from colds and flus[vi]
- Reduced risk of heart disease[vii]
- Improved symptoms of anxiety and depression[viii]
- Antiaging effects[ix]
There are many delicious options for adding fermented foods and beverages to your diet. Fermenting foods imbues them with a complex flavor profile and a tart, tanginess that can be enjoyed at breakfast, lunch and dinner. If you’re new to fermented foods, start by adding a couple of teaspoons to your plate as an addition to regular meals.
You can work up to enjoying fermented foods as mainstays of your diet, and even create new recipes for you and your family to enjoy. Your body — and your microbiome — will thank you for it for years to come.
Top Five Traditional Fermented Foods
- Yogurt
Yogurt is a popular fermented milk product with a sour taste and creamy texture. Most yogurts contain bacterial cultures, however products can vary in the amount of probiotics they contain, so be conscious when reading labels. If you purchase yogurt, look for “live and active cultures” on the container or a guaranteed minimum viable bacteria count, and avoid the many heavily sugared brands.
Yogurt is also remarkably simple to make at home, requiring only a saucepan or pressure cooker to boil the milk, and starter cultures to begin the fermentation process. Most commercial yogurts contain acidophilus bacterium or bifidobacterium lactis, which you can add using liquid or powdered probiotics or by adding a small amount of an existing batch of yogurt.
If you can’t drink milk without digestive upset and think yogurt is off limits, fermented dairy products may be an exception. Fermentation helps break down lactose, the natural sugar in milk, so even individuals with lactose intolerance may be able to digest yogurt and kefir without difficulty.[x] Kefir is a yogurt-like drink with a thinner consistency and higher protein than yogurt but possessing the same digestive benefits.[xi]
The benefits of fermented milk products are not exclusive to dairy milk. Vegans and dairy-averse individuals can find several varieties of non-dairy yogurt in most health food stores, including soy, almond, and coconut milk yogurts.
- Fermented Vegetables
Fermenting vegetables is a great way to get the health benefits of probiotics in a way that suits your personal taste. Cultures from around the world have been fermenting native varieties of produce for centuries as a way to preserve food before modern refrigeration. While freshly picked vegetables may only be viable for a matter of days, fermenting vegetables in brine and storing in air-tight jars can increase shelf-life to several months.[xii]
You can find easy inspiration for your fermentation adventures from traditional multicultural recipes like Korean kimchi. A spicy pickled condiment made from cabbage and red chili, kimchi has been associated with anticancer properties.[xiii] Kimchi is also credited with antiaging effects due to its ability to decrease free radical production.[xiv]
Other traditional options for fermenting vegetables include raw sauerkraut and pickled cucumbers, cauliflower and even leafy greens like mustard and collard. Don’t forget to add flavorful spices such as dill and coriander, or for a spicier mix include garlic, ginger and chilis or hot peppers.
- Kombucha
Kombucha is a tart, fizzy, fermented tea beverage that has become something of a cultural zeitgeist. Popular with health enthusiasts of all ages, you can step up to a kombucha bar in many urban centers and take classes on how to brew your own Instagram-worthy bottles in a multitude of exotic flavors.
Kombucha is brewed using a batch of sweetened tea and a bacteria and yeast pancake called a SCOBY (symbiotic culture of bacteria and yeast). Both green and black tea can be used, however black tea and white sugar are considered the finest mediums for traditional kombucha.[xv]
The SCOBY floats in the tea, feeding on the sugary elixir, growing in size and eventually sealing off the liquid at the top like a raft. This keeps potential harmful bacteria at bay and creates the ideal anaerobic conditions for fermentation. A ratio of 50 grams of sucrose per liter of purified water has been used in traditional recipes and is considered the optimal concentration of ethanol and lactic acid.[xvi]
Leave the brew in a lightly covered jar at room temperature (70° to 80°F) for one to three weeks; the longer the tea is allowed to ferment, the stronger and tarter it becomes. Once the brew has achieved desired strength, transfer the liquid into individual bottles where it can be flavored with fresh or candied fruits, ginger slices, raisins, vanilla and the like.
Transfer the now-larger SCOBY (it will add a layer with every batch) to a new container to begin the process again, or store it in a small amount of tea in a sealed jar in the refrigerator to slow the growth process. The bottled tea can be stored at room temperature for one to two weeks to encourage carbonation, after which time it should be refrigerated.
Experimenting with flavors and potency is part of the fun, and recipes can be modified to suit individual taste preferences. Be sure to use impeccably clean equipment in your process to ensure that no harmful bacteria are introduced.
Besides being delicious, healthful and fun to make, there are at least 18 healthy reasons to sip kombucha. Kombucha’s antioxidant activity has been found to be 100 times higher than vitamin C and 25 times higher than vitamin E.[xvii]Kombucha’s high levels of vitamin C boost immunity, and its antioxidant power protects against cell damage, inflammatory diseases, suppressed immunity and tumors.[xviii] Kombucha has also been shown to be effective for prevention against broad-spectrum metabolic and infective disorders.[xix]
- Apple Cider Vinegar
Made by fermenting apple juice with yeast, apple cider vinegar, or ACV, is a staple of health food kitchens the world-over. Used to make salad dressing, marinades and baked goods, ACV is also used in many food-based personal care recipes due to its ability to add shine to hair and clarity to your complexion. Good bacteria from the yeast convert alcohol that develops during fermentation into acetic acid, which is responsible for ACV’s distinctive sharp, sour smell and taste.[xx]
ACV is attributed with antidiabetic and antioxidant effects that make it a useful ally in the fight against diabetes,[xxi] a common problem in the developed world. A 2017 study of obese rats found that a daily dose of ACV attenuated oxidative stress and reduced the risk of heart attack associated with obesity-related cardiovascular disease.[xxii]
Other beneficial metabolic effects attributed to small, daily doses of ACV include balancing cholesterol[xxiii] and offering natural antimicrobial activity,[xxiv]especially useful in our age of growing antibiotic resistance.
Because of its high acidity, consuming too much ACV can be irritating to your teeth, throat and stomach. As a supplement to daily health maintenance, it’s recommended to start with no more than 2 tablespoons of ACV diluted with equal parts water, taken on an empty stomach immediately upon waking as a jump-start to your daily digestive processes.
- Miso
A traditional staple of the Japanese diet, miso — fermented soybean paste — is credited with saving the lives of 21 health care workers stationed less than 2 kilometers from ground zero, Nagasaki, Japan, on August 9, 1945.[xxv]
Dr. Tatuichiro Akizuki, a physician, credited this miracle to the fact that everyone was consuming daily cups of miso soup garnished with wakame seaweed.[xxvi] A 2003 study from the Research Institute for Radiation Biology and Medicine at Hiroshima University showed that miso does, in fact, have the ability to prevent radiation injury.[xxvii]
Made by combining a mash of soybeans and grains with sea salt and koji (a mold starter), the mixture is fermented for three months to three years, depending on the strength of flavor desired. The resulting enzyme-rich paste contains vitamins, salts, minerals, plant proteins, carbohydrates, fat and living microorganisms. The potent, salty flavor of miso makes it a great base for soups and sauces and for flavoring meat substitutes like tempeh.
Proof that not everything that’s good for you has to be bland, frequent, long-term consumption of miso soup has been associated with a reduced risk of breast cancer[xxviii] and reduced risk of heart disease.[xxix] Fermented soy products have also demonstrated effectiveness at staving off bone diseases like osteoporosis
Protective effect of curcumin against bone trauma
People’s Liberation Army (China), December 10, 2020
According to news reporting out of Shandong, People’s Republic of China, research stated, “Bone fracture, a common injury to bones leads to various biophysiological changes and pathological responses in the body. The current study investigated curcumin for treatment of bone fracture in a rat model of bone trauma, and evaluated the related mechanism.”
Our news journalists obtained a quote from the research from People’s Liberation Army, “The rats were separated randomly into 3 groups; sham, model, and curcumin treatment groups. The fracture rat model was established by transverse osteotomy in the right femur bone at the mid-shaft. The osteoblast count was determined using hematoxylin and eosin staining. Vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) expression were measured by western blotting. The rpS6-phosphorylation was suppressed and light chain 3 (LC3II) expression elevated in the curcumin treated group of the fracture rat model. In the curcumin-treated group, mineralization of fracture calluses was markedly higher on day 14 of fracture. The formation of osteoblasts was observed at a greater rate in the curcumin treated group compared to the model rat group. Treatment of rats with curcumin significantly (P <0.05) promoted expression of PCNA and VEGF. The decrease in CD11b+/Gr-1+ cell expansion in rats with bone trauma was alleviated significantly by curcumin treatment. A marked increase in arginase-1 expression in rats with bone trauma was caused by curcumin treatment. In summary, curcumin activates autophagy and inhibits mTOR activation in bone tissues of rats with trauma. The curcumin promoted myeloid-derived suppressor cell (MDSC) proliferation and increased expansion of MDSCs in a rat model of trauma.”
According to the news editors, the research concluded: “Therefore, curcumin may have beneficial effect in patients with bone trauma and should be evaluated further for development of treatment.”
Obesity Impairs Immune Cell Function
Harvard Medical School, December 11, 2020
According to a recent study from Harvard Medical School, high-fat diets allow cancer cells to outcompete immune cells for fuel, this impairs immune function and accelerates tumor growth in mice studies. This is done by cancer cells rewiring their metabolisms to increase fat consumption, and blocking the rewiring enhances anti-tumor immunity.
Over the years obesity has been linked to an increased risk for various different types of cancer, as well as a worse prognosis and survial. Obesity-related processes have been identified that drive tumor growth such as metabolic changes and chronic inflammation, but a detailed understanding of the mechanisms between obesity and cancer remains unknown.
Finding published in Cell may help to reveal a piece to this puzzle and may have surprising implications for cancer immunotherapy in that obesity allows cancer cells to outcompete tumour-killing immune cells in a battle for energy/fuel. The report describes how a high-fat diet reduces the numbers and antitumor activity of CD8+ T-cells which are critical immune cells inside of tumors. This happens because cancer cells can reprogram their metabolism in response to increased fat availability to better absorb the energy-rich fat molecules, thus depriving T-cells of fuel and accelerating tumor growth.
“Putting the same tumor in obese and nonobese settings reveals that cancer cells rewire their metabolism in response to a high-fat diet,” said Marcia Haigis, professor of cell biology in the Blavatnik Institute at HMS and co-senior author of the study. “This finding suggests that a therapy that would potentially work in one setting might not be as effective in another, which needs to be better understood given the obesity epidemic in our society.“
Blocking this fat-related metabolic cell reprogramming was found to significantly reduce tumor volume in mice who were fed high-fat diets. In this study, the effects of obesity were investigated in mouse models of different types of cancer. The animals were fed either normal or high-fat diets, with the HFD leading to increased body weight and other obesity-related changes. Then the team examined different cell types and molecules inside and around the tumors/ the tumor microenvironment. Finding may suggest new strategies for improving immunotherapies that activate the immune system against cancer as CD8+ T-cells are the main weapons used in such therapies.
“Cancer immunotherapies are making an enormous impact on patients’ lives, but they do not benefit everyone,” said co-senior author Arlene Sharpe, the HMS George Fabyan Professor of Comparative Pathology and chair of the Department of Immunology in the Blavatnik Institute.
“We now know there is a metabolic tug-of-war between T cells and tumor cells that changes with obesity,” Sharpe said. “Our study provides a roadmap to explore this interplay, which can help us to start thinking about cancer immunotherapies and combination therapies in new ways.”
Fatty Paradox
The researchers found that tumors grew much more rapidly in animals on high-fat diets compared to those on normal diets. But this occurred only in cancer types that are immunogenic, which can contain high numbers of immune cells; are more easily recognized by the immune system; and are more likely to provoke an immune response.
Experiments revealed that diet-related differences in tumor growth depended specifically on the activity of CD8+ T cells, immune cells that can target and kill cancer cells. Diet did not affect tumor growth rate if CD8+ T cells were eliminated experimentally in mice.
Strikingly, high-fat diets reduced the presence of CD8+ T cells in the tumor microenvironment, but not elsewhere in the body. Those remaining in the tumor were less robust — they divided more slowly and had markers of decreased activity. But when these cells were isolated and grown in a lab, they had normal activity, suggesting something in the tumor impaired these cells’ function.
The team also encountered an apparent paradox. In obese animals, the tumor microenvironment was depleted of key free fatty acids, a major cellular fuel source, even though the rest of the body was enriched in fats, as expected in obesity.
These clues pushed the researchers to craft a comprehensive atlas of the metabolic profiles of different cell types in tumors under normal and high-fat diet conditions.
The analyses revealed that cancer cells adapted in response to changes in fat availability. Under a high-fat diet, cancer cells were able to reprogram their metabolism to increase fat uptake and utilization, while CD8+ T cells did not. This ultimately depleted the tumor microenvironment of certain fatty acids, leaving T cells starved for this essential fuel.
“The paradoxical depletion of fatty acids was one of the most surprising findings of this study. It really blew us away and it was the launch pad for our analyses,” said Ringel, a postdoctoral fellow in the Haigis lab. “That obesity and whole-body metabolism can change how different cells in tumors utilize fuel was an exciting discovery, and our metabolic atlas now allows us to dissect and better understand these processes.“
Hot And Cold
Through several different approaches, including single-cell gene expression analyses, large-scale protein surveys and high-resolution imaging, the team identified numerous diet-related changes to metabolic pathways of both cancer and immune cells in the tumor microenvironment.
Of particular interest was PHD3, a protein that in normal cells has been shown to act as a brake on excessive fat metabolism. Cancer cells in an obese environment had significantly lower expression of PHD3 compared to in a normal environment. When the researchers forced tumor cells to overexpress Ph.D., they found that this diminished a tumor’s ability to take up fat in obese mice. It also restored the availability of key free fatty acids in the tumor microenvironment.
Increased PHD3 expression largely reversed the negative effects of a high-fat diet on immune cell function in tumors. Tumors with high PHD3 grew slower in obese mice compared to tumors with low PHD3. This was a direct result of increased CD8+ T cell activity. In obese mice lacking CD8+ T cells, tumor growth was unaffected by differences in PHD3 expression.
The team also analyzed human tumor databases and found that low PHD3 expression was associated with immunologically “cold” tumors, defined by fewer numbers of immune cells. This association suggested that tumor fat metabolism plays a role in human disease, and that obesity reduces antitumor immunity in multiple cancer types, the authors said.
“CD8+ T cells are the central focus of many promising precision cancer therapies, including vaccines and cell therapies such as CAR-T,” Sharpe said. “These approaches need T cells to have sufficient energy to kill cancer cells, but at the same time we don’t want tumors to have fuel to grow. We now have amazingly comprehensive data for studying this dynamic and determining mechanisms that prevent T cells from functioning as they should.”
More broadly, the results serve as a foundation for efforts to better understand how obesity affects cancer and the impact of patient metabolism on therapeutic outcomes, the authors said. While it’s too early to tell if PHD3 is the best therapeutic target, the findings open the door for new strategies to combat cancer through its metabolic vulnerabilities, they said.
“We’re interested in identifying pathways that we could use as potential targets to prevent cancer growth and to increase immune antitumor function,” Haigis said. “Our study provides a high-resolution metabolic atlas to mine for insights into obesity, tumor immunity and the crosstalk and competition between immune and tumor cells. There are likely many other cell types involved and many more pathways to be explored.”
Green tea extract EGCG plays dual role in amyloid beta 42 protofibril disruption and membrane protection
Fudan University (China), December 14, 2020
According to news reporting from Shanghai, People’s Republic of China, research stated, “Amyloid plaques accumulated by the amyloid-b (Ab) fibrillar aggregates are the major pathological hallmark of the Alzheimer’s disease (AD). Inhibiting aggregation and disassembling preformed fibrils of Ab by natural small molecules have developed into a promising therapeutic strategy for AD.”
The news correspondents obtained a quote from the research from Fudan University, “Previous experiments reported that the green tea extract epigallocatechin-3-gallate (EGCG) can disrupt Ab fibril and reduce Ab cytotoxicity. The inhibitory ability of EGCG can also be affected by cellular membranes. Thus, it is essential to consider the membrane influences in the investigation of protofibril-disruptive capability of EGCG. Here, we performed multiple all-atom molecular dynamic simulations to investigate the effect of EGCG on the Ab protofibril in the presence of a mixed POPC/POPG (7:3) lipid bilayer and the underlying molecular mechanisms of action. Our simulations show that in the presence of membrane bilayer, EGCG has a preference to bind to the membrane, and this binding alters the binding modes between Ab protofibril and the lipid bilayer, leading to a reduced membrane thinning, indicative of a protective effect of EGCG on the membrane. And EGCG still displays a disruptive effect on Ab protofibril, albeit with a lesser extent of disruption than that in the membrane-free environment. EGCG destabilizes the two hydrophobic core regions (L17-F19-I31 and F4-L34-V36), and disrupts the intrachain K28-A42 side chain salt bridges.”
According to the news reporters, the research concluded: “Our results reveal that in the presence of lipid bilayers, EGCG plays a dual role in Ab protofibril disruption and membrane protection, suggesting that EGCG could be a potential effective drug candidate for the treatment of AD.”
Omega-3 supplements don’t raise bad cholesterol
Fatty Acid Research Institute and Cooper Institute, December 18, 2020
The Fatty Acid Research Institute (FARI) has published a new research paper in conjunction with The Cooper Institute on the omega-3s EPA and DHA in fish oil and low density lipoprotein cholesterol (LDL-C).
Omega-3 fatty acids have a long history of being “heart healthy,” and are well-known for lowering blood levels of triglycerides (but typically not cholesterol). Recent questions have been raised, however, about one of the two “fish oil” omega-3 fatty acids — DHA (docosahexaenoic acid) — and the possibility that it might actually raise levels of LDL-C, the “bad” cholesterol.
There is good evidence that people with very high serum triglyceride levels (>500 mg/dL) who are treated with high doses of omega-3, i.e., 4 g/day of EPA (eicosapentaenoic acid) and DHA commonly see a rise in LDL-C, whether this occurs in the “real world” with generally healthy people taking fish oil supplements for cardioprotection is not clear.
A recent study from the Cooper Center Longitudinal Study (CCLS) and FARI sheds new light on this question.
The investigators utilized data from 9253 healthy men and women who had at least two preventive medical examinations at Cooper Clinic in Dallas over a 10-year period. These examinations routinely included both blood cholesterol testing and measurement of the Omega-3 Index (i.e., red blood cell (RBC) EPA+DHA levels from OmegaQuant Analytics). Questions about current use of fish oil supplements was also collected.
With this information, the researchers then asked 2 questions: 1) did people who started taking fish oil supplements between visits experience a rise in LDL-C levels, and 2) did LDL-C levels rise in people whose RBC DHA levels increased between visits?
It turns out that the answer to both of these questions was “no.” In fact, a 1-unit rise in RBC DHA levels was associated with a small (1-2 mg/dL) but statistically significant decrease in LDL-C. And this analysis took into account concurrent changes in background use of cholesterol-lowering drugs like statins. This small decrease in LDL-C is not a clinically-relevant, but this study shows that fish oil supplement use in the general population does not adversely affect LDL-C.
Dr. William Harris, President of FARI and co-inventor of the Omega-3 Index, was the lead author on this study. In his view, “these new findings from the CCLS clearly show that people who take fish oil supplements need not worry about adversely affecting their cholesterol levels as some have proposed.”
He also noted that these results also harmonize well with the conclusions of a recent American Heart Association Advisory on the use of omega-3 fatty acids in the treatment of high triglyceride levels. This major review found there is “no strong evidence that DHA-containing prescription omega-3 fatty acid agents used alone or in combination with statins raise LDL-C in patients with high triglyceride levels.1”
Commenting on this paper, Dr. Carl Lavie, a cardiologist and Medical Director of the Cardiac Rehabilitation and Prevention Program at the John Ochsner Heart and Vascular Institute in New Orleans, LA, said, “This large study from the Cooper Clinic indicates that RBC DHA levels are not associated with higher LDL-cholesterol levels (actually with lower), and adding omega-3 supplements was also not associated with increases in LDL-C.”
Dr. Lavie and colleagues recently published data from 40 studies in over 135,000 participants in the Mayo Clinic Proceedings indicating that the combined EPA and DHA dose predicted reductions in major cardiovascular outcomes2. “These new data from the Cooper Institute add to the cumulative evidence of the safety and efficacy of omega-3 from dietary sources and supplements, including the combination of EPA and DHA,” he said.
Intake of seven essential amino acids improves cognitive function and psychological and social function in middle-aged and older adults
Tokyo Metropolitan Institute of Gerontology, December 18, 2020
According to news originating from Tokyo, Japan, the research stated, “To delay the onset of dementia, it is important for healthy adults to take preventive actions before the cognitive function clearly declines. Protein malnutrition is a potential risk factor for senile dementia, although the precise link between protein/amino acid nutrition and cognitive function is unknown.”
Our news journalists obtained a quote from the research from Tokyo Metropolitan Institute of Gerontology: “The purpose of this study was to examine the effect of the ingestion of seven selected essential amino acids as a granular powder, namely, leucine, phenylalanine, and lysine supplemented with isoleucine, histidine, valine, and tryptophan on cognitive and psychosocial functions in healthy adults. A double-blind, randomized, placebo-controlled trial was conducted. A total of 105 participants aged 55 years or older were randomly assigned to one of three groups: daily ingestion of 3 g (3gIG) or 6 g (6gIG) of the selected amino acids or daily ingestion of a placebo (PCG). Each group ingested the test powder for 12 weeks. As the main outcome, cognitive function was assessed before and after ingestion by a cognitive test battery. Psychosocial functions were also examined. The numbers of participants excluding dropouts were 35 in PCG and 3gIG and 33 in 6gIG. Analysis of covariance revealed that the 6gIG showed significantly improved cognitive function (Trail Making Test B), social interaction and psychological health scores after ingestion compared to the PCG (multiplicity adjusted p < 0.05).”
According to the news reporters, the research concluded: “Current findings suggested that ingestion of the seven essential amino acids led to improved attention and cognitive flexibility and psychosocial functioning, which is expected to prevent cognitive decline.
Effect of Lactobacillus sakei, a Probiotic Derived from Kimchi, on Body Fat and Obesity: A Randomized Controlled Study
Seoul National University College of Medicine, December 1, 2020
A 2020 study investigates whether Lactobacillus sakei (L. sakei) bacteria derived from kimchi, a staple food in Korea, can contribute to weight loss in obese individuals.
L. Sakei Influence on Obesity and Gut Microbiota
L. sakei, commonly found in meat and fish, is used to ferment meat in Western countries. A previous study showed that its eight-week intake from Korean kimchi significantly slashed body weight and fat mass in animal models with high-fat diet-induced obesity.[iv]
The new randomized, double-blind, placebo-controlled clinical trial involved 114 obese individuals, or those with a body mass index (BMI) of more than 25 kg/m2.[v] The participants were randomly assigned to the L. sakei or placebo group for 12 weeks. The researchers then measured changes in body fat, weight and waist circumference.
After 12 weeks, the researchers saw a 0.2 kg reduction in body fat mass in the L. sakei group while finding a 0.6 kg increase in the placebo group. Waist circumference was also 0.8 centimeters (cm) smaller in the L. sakei subjects than those in the placebo group. BMI and body weight did not change, and adverse events were mild and similar between the groups.
Data suggested that L. sakei might be helpful in reducing body fat mass in obese individuals without serious side effects.
While recognizing limitations in their study, including the need to probe significant body fat and weight changes beyond 12 weeks of treatment, the researchers cited evidence that food changes the human gut microbiota — and diet plays an important role in the gut’s bacterial environment and the progression of obesity. The gut microbiota is an extremely complex, abundant group of microbes that colonize the human body and radically influence health.[vi]
“[C]hanges in the composition of the gut microbiota may contribute to alterations in body weight and composition,” the researchers wrote.[vii]
Gut-derived short-chain fatty acids (SCFAs) have been previously found to cause weight regulation through their stimulatory impact on anorexigenic (appetite suppressing) gut hormones and in the increase in the synthesis of the satiety hormone leptin.[viii]
Kimchi and Overall Wellness
Kimchi, consumed by Koreans as a salted and fermented vegetable side dish for about 2,000 years, packs so many health benefits as a probiotic. All of kimchi’s traditional ingredients are health-boosting foods in their own right: cruciferous vegetables, garlic, ginger and red pepper, to name a few. Here are other studies that point to kimchi’s wondrous effects on human wellness:
- Strong immune system — A study concluded that the probiotic Lactobacillus plantarum (L. plantarum) 200655 isolated from kimchi has antioxidant and immune-enhancing properties.[ix] This makes the strain ideal for older people.
- Anticancer action — Korean researchers developed a kimchi recipe boosting its anticancer action, adding mustard leaf, Chinese pepper and Korean mistletoe extract. Lab tests on human colon cancer cells revealed that the mistletoe extract increased inhibition rate from 62% to 80%.[x]
In a long-term study, a Chinese group found that Helicobacter pylori (H. pylori) treatment for two weeks coupled with vitamin or garlic supplementation for seven years were associated with a significantly reduced risk of death from gastric cancer for over 22 years.[xi]
Both treatments were also linked with greatly reduced incidence of the cancer. Kimchi, with its known anti-carcinogenic potential,[xii] is made from Chinese cabbage — this vegetable contains sulforaphane, a potent H. pylori-fighting compound.
- Anti-diarrhea — Exopolysaccharide from L. plantarum offered protection against rotavirus-induced diarrhea and regulated inflammatory
response. The probiotic strain was one among 263 strains found in 35 samples of kimchi.[xiii] - Healthy lipid profile — In a study of 102 healthy Korean men ages 40 to 64 years, researchers associated eating up to 453 g of kimchi a day with higher HDL cholesterol and lower levels of LDL cholesterol
Difference in blood pressure between arms linked to greater death risk
University of Exeter (UK), December 20, 2020
Robust evidence from a large international study confirms that a difference in blood pressure readings between arms is linked to greater risk of heart attack, stroke and death.
Led by the University of Exeter, the global INTERPRESS-IPD Collaboration conducted a meta-analysis of all the available research, then merged data from 24 global studies to create a database of nearly 54,000 people. The data spanned adults from Europe, the US, Africa and Asia for whom blood pressure readings for both arms were available.
Funded by the National Institute for Health Research (NIHR) and published today in Hypertension, the study is the first to conclude that the greater the inter-arm blood pressure difference, the greater the patient’s additional health risk.
Currently, international blood pressure guidelines advise health professionals to measure blood pressure in both arms when assessing cardiovascular risk,- yet this is widely ignored. The new study provides a new upper limit of ‘normal’ for an inter-arm difference in blood pressure, which is significantly lower than the current guidance. The research could lead to a change in international hypertension guidelines, meaning more at-risk patients could be identified and receive potentially life-saving treatment.
In a methodology that put patients at its heart, working with a patient advisory group at every step of the research, the team analysed data on inter-arm blood pressure difference, and tracked the number of deaths, heart attacks and strokes that occurred in the cohort over 10 years.
Lead author and GP Dr Chris Clark, of the University of Exeter Medical School, said: “Checking one arm then the other with a routinely used blood pressure monitor is cheap and can be carried out in any healthcare setting, without the need for additional or expensive equipment. Whilst international guidelines currently recommend that this is done, it only happens around half of the time at best, usually due to time constraints. Our research shows that the little extra time it takes to measure both arms could ultimately save lives”.
“We’ve long known that a difference in blood pressure between the two arms is linked to poorer health outcomes. The large numbers involved in the INTERPRESS-IPD study help us to understand this in more detail. It tells us that the higher the difference in blood pressure between arms, the greater the cardiovascular risk, so it really is critical to measure both arms to establish which patients may be at significantly increased risk. Patients who require a blood pressure check should now expect that it’s checked in both arms, at least once.”
Blood pressure rises and falls in a cycle with each pulse. It is measured in units of millimetres of mercury (mmHg), and the reading is always given as two numbers: the upper (systolic) reading represents the maximum blood pressure and the lower (diastolic) value is the minimum blood pressure. A high systolic blood pressure indicates hypertension. This affects one third of the adult population and is the single leading cause globally of preventable heart attacks, strokes and deaths. A significant difference between the systolic blood pressure measurements in the two arms could be indicative of a narrowing, or a stiffening, of the arteries, which can affect blood flow. These arterial changes are recognised as a further risk marker for subsequent heart attack, stroke or early death, and should be investigated for treatment.
The researchers concluded that each mmHg difference found between the two arms, elevated predicted 10-year risk of one of the following occurring by one percent; new angina, a heart attack or stroke.
At the moment, both UK and European guidelines recognise a systolic difference of 15 mmHg or more between the two arms as the threshold indicative of additional cardiovascular risk. This new study found that a lower threshold of 10 mmHg was clearly indicative of additional risk, which would mean that far more people should be considered for treatment if such a difference between arms is present. To this end, the research team has created a tool that is easy for clinicians to use, to establish who should be considered for treatment based on their risk, incorporating the blood pressure reading in both arms.
Research co-author Professor Victor Aboyans, head of the department of cardiology at the Dupuytren University Hospital in Limoges, France, said “We believe that a 10 mmHg difference can now reasonably be regarded as an upper limit of normal for systolic inter-arm blood pressure, when both arms are measured in sequence during routine clinical appointments. This information should be incorporated into future guidelines and clinical practice in assessing cardiovascular risk. It would mean many more people were considered for treatment that could reduce their risk of heart attack, stroke and death.”
An interarm difference of greater than 10 mmHg occurs in 11 per cent of people with high blood pressure (hypertension) – itself a known health risk – and in four per cent of the general population.
Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4037 (Published 21 October 2020)Cite this as: BMJ 2020;371:m4037 Peter Doshi, associate editor
The world has bet the farm on vaccines as the solution to the pandemic, but the trials are not focused on answering the questions many might assume they are. Peter Doshi reports
As phase III trials of covid-19 vaccines reach their target enrolments, officials have been trying to project calm. The US coronavirus czar Anthony Fauci and the Food and Drug Administration leadership have offered public assurances that established procedures will be followed.1234 Only a “safe and effective” vaccine will be approved, they say, and nine vaccine manufacturers issued a rare joint statement pledging not to prematurely seek regulatory review.5
But what will it mean exactly when a vaccine is declared “effective”? To the public this seems fairly obvious. “The primary goal of a covid-19 vaccine is to keep people from getting very sick and dying,” a National Public Radio broadcast said bluntly.6
Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, said, “Ideally, you want an antiviral vaccine to do two things . . . first, reduce the likelihood you will get severely ill and go to the hospital, and two, prevent infection and therefore interrupt disease transmission.”7
Yet the current phase III trials are not actually set up to prove either (table 1). None of the trials currently under way are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus.
Table 1
Characteristics of ongoing phase III covid-19 vaccine trials
Evaluating mild, not severe, disease
In a September interview Medscape editor in chief Eric Topol pondered what counts as a recorded “event” in the vaccine trials. “We’re not talking about just a PCR [polymerase chain reaction test]-positive mild infection. It has to be moderate to severe illness to qualify as an event, correct?” he asked.8
“That’s right,” concurred his guest, Paul Offit, a vaccinologist who sits on the FDA advisory committee that may ultimately recommend the vaccines for licence or emergency use authorisation.
But that’s not right. In all the ongoing phase III trials for which details have been released, laboratory confirmed infections even with only mild symptoms qualify as meeting the primary endpoint definition.9101112 In Pfizer and Moderna’s trials, for example, people with only a cough and positive laboratory test would bring those trials one event closer to their completion. (If AstraZeneca’s ongoing UK trial is designed similarly to its “paused” US trial for which the company has released details, a cough and fever with positive PCR test would suffice.)
Part of the reason may be numbers. Severe illness requiring hospital admission, which happens in only a small fraction of symptomatic covid-19 cases, would be unlikely to occur in significant numbers in trials. Data published by the US Centers for Disease Control and Prevention in late April reported a symptomatic case hospitalisation ratio of 3.4% overall, varying from 1.7% in 0-49 year olds and 4.5% in 50-64 year olds to 7.4% in those 65 and over.13Because most people with symptomatic covid-19 experience only mild symptoms,14 even trials involving 30 000 or more patients would turn up relatively few cases of severe disease.
In the trials, final efficacy analyses are planned after just 150 to 160 “events,”—that is, a positive indication of symptomatic covid-19, regardless of severity of the illness.
Yet until vaccine manufacturers began to release their study protocols in mid-September, trial registries and other publicly released information did little to dispel the notion that it was severe covid-19 that the trials were assessing. Moderna, for example, called hospital admissions a “key secondary endpoint” in statements to the media.15 And a press release from the US National Institutes of Health reinforced this impression, stating that Moderna’s trial “aims to study whether the vaccine can prevent severe covid-19” and “seeks to answer if the vaccine can prevent death caused by covid-19.”16
But Tal Zaks, chief medical officer at Moderna, told The BMJ that the company’s trial lacks adequate statistical power to assess those outcomes. “The trial is precluded from judging [hospital admissions], based on what is a reasonable size and duration to serve the public good here,” he said.
Hospital admissions and deaths from covid-19 are simply too uncommon in the population being studied for an effective vaccine to demonstrate statistically significant differences in a trial of 30 000 people. The same is true of its ability to save lives or prevent transmission: the trials are not designed to find out.
Zaks said, “Would I like to know that this prevents mortality? Sure, because I believe it does. I just don’t think it’s feasible within the timeframe [of the trial]—too many would die waiting for the results before we ever knew that.”
Stopping transmission
What about Hotez’s second criterion, interrupting virus transmission, which some experts have argued17 should be the most important test in phase III studies?
“Our trial will not demonstrate prevention of transmission,” Zaks said, “because in order to do that you have to swab people twice a week for very long periods, and that becomes operationally untenable.”
He repeatedly emphasised these “operational realities” of running a vaccine trial. “Every trial design, especially phase III, is always a balancing act between different needs,” he said. “If you wanted to have an answer on an endpoint that happens at a frequency of one 10th or one fifth the frequency of the primary endpoint, you would need a trial that is either 5 or 10 times larger or you’d need a trial that is 5 or 10 times longer to collect those events. Neither of these, I think, are acceptable in the current public need for knowing expeditiously that a vaccine works.”
Zaks added, “A 30 000 [participant] trial is already a fairly large trial. If you’re asking for a 300 000 trial then you need to talk to the people who are paying for it, because now you’re talking about not a $500m to $1bn trial, you’re talking about something 10 times the size. And I think the public purse and operational capabilities and capacities we have are rightly spent not betting the farm on one vaccine but, as Operation Warp Speed [the US government’s covid-19 vaccine plan] is trying to do, making sure that we’re funding several vaccines in parallel.”
Debating endpoints
Still, it’s fair to say that most of the general public assumes that the whole point of the current trials, besides testing safety (box 1), is to see whether the vaccine can prevent bad outcomes. “How do you reconcile that?” The BMJasked Zaks.
Box 1
Safety and side effects
History shows many examples of serious adverse events from vaccines brought to market in periods of enormous pressure and expectation. There were contaminated polio vaccines in 1955, cases of Guillain-Barré syndrome in recipients of flu vaccines in 1976, and narcolepsy linked to one brand of influenza vaccine in 2009.1819
“Finding severe rare adverse events will require the study of tens of thousands of patients, but this requirement will not be met by early adoption of a product that has not completed its full trial evaluation,” Harvard drug policy researchers Jerry Avorn and Aaron Kesselheim recently wrote in JAMA.20
Covid-19 vaccine trials are currently designed to tabulate final efficacy results once 150 to 160 trial participants develop symptomatic covid-19—and most trials have specified at least one interim analysis allowing for the trials to end with even fewer data accrued.
Medscape’s Eric Topol has been a vocal critic of the trials’ many interim analyses. “These numbers seem totally out of line with what would be considered stopping rules,” he says. “I mean, you’re talking about giving a vaccine with any of these programmes to tens of millions of people. And you’re going to base that on 100 events?”8
Great uncertainty remains over how long a randomised trial of a vaccine will be allowed to proceed. If efficacy is declared, one possibility is that the thousands of volunteers who received a saline placebo would be offered the active vaccine, in effect ending the period of randomised follow-up. Such a move would have far reaching implications for our understanding of vaccines’ benefits and harms, rendering uncertain our knowledge of whether the vaccines can reduce the risk of serious covid-19 disease and precluding any further ability to compare adverse events in the experimental versus the placebo arm.
“It’ll be a decision we’ll have to take at that time. We have not committed one way or another,” Moderna’s Tal Zaks told The BMJ. “It will be a decision where FDA and NIH will also weigh in. And it will be probably a very difficult decision, because you will be weighing the benefit to the public in continuing to understand the longer term safety by keeping people on placebo and the expectation of the people who have received placebo to be crossed over now that it has been proved effective.”
“Very simply,” he replied. “Number one, we have a bad outcome as our endpoint. It’s covid-19 disease.” Moderna, like Pfizer and Janssen, has designed its study to detect a relative risk reduction of at least 30% in participants developing laboratory confirmed covid-19, consistent with FDA and international guidance.2122
Number two, Zaks pointed to influenza vaccines, saying they protect against severe disease better than mild disease. To Moderna, it’s the same for covid-19: if its vaccine is shown to reduce symptomatic covid-19, it will be confident it also protects against serious outcomes.
But the truth is that the science remains far from clear cut, even for influenza vaccines that have been used for decades. Although randomised trials have shown an effect in reducing the risk of symptomatic influenza, such trials have never been conducted in elderly people living in the community to see whether they save lives.
Only two placebo controlled trials in this population have ever been conducted, and neither was designed to detect any difference in hospital admissions or deaths.23 Moreover, dramatic increases in use of influenza vaccines has not been associated with a decline in mortality (box 2).26
Box 2
Not enrolling enough elderly people or minorities
A vaccine that has been proved to reduce the risk of symptomatic disease by a certain proportion should, you might think, reduce serious outcomes such as hospital admissions and deaths in equal proportion.
Peter Marks, an FDA official with responsibility over vaccine approvals, recently stated as much about influenza vaccination, which “only prevents flu in about half the people who get it. And yet that’s very important because that means that it leads to half as many deaths related to influenza each year.”24
But when vaccines are not equally effective in all populations the theory breaks down.
If frail elderly people, who are understood to die in disproportionate numbers from both influenza25 and covid-19, are not enrolled into vaccine trials in sufficient numbers to determine whether case numbers are reduced in this group, there can be little basis for assuming any benefit in terms of hospital admissions or mortality. Whatever reduction in cases is seen in the overall study population (most of which may be among healthy adults), this benefit may not apply to the frail elderly subpopulation, and few lives may be saved.
This is hard to evaluate in the current trials because there are large gaps in the types of people being enrolled in the phase III trials (table 1). Despite recruiting tens of thousands, only two trials are enrolling children less than 18 years old. All exclude immunocompromised people and pregnant or breastfeeding women, and though the trials are enrolling elderly people, few or perhaps none of the studies would seem to be designed to conclusively answer whether there is a benefit in this population, despite their obvious vulnerability to covid-19.
“Adults over 65 will be an important subgroup that we will be looking at,” Moderna’s Zaks told The BMJ. “That said . . . any given study is powered for its primary endpoint—in our case covid-19 disease irrespective of age.”
Al Sommer, dean emeritus of the Johns Hopkins School of Public Health, told The BMJ, “If they have not powered for evidence of benefit in the elderly, I would find that a significant, unfortunate shortcoming.” He emphasised the need for “innovative follow-up studies that will enable us to better determine the direct level of protection immunisation has on the young and, separately, the elderly, in addition to those at the highest risk of severe disease and hospitalisation.”
One view is that trial data should be there for all target populations. “If we don’t have adequate data in the greater than 65 year old group, then the greater than 65 year old person shouldn’t get this vaccine, which would be a shame because they’re the ones who are most likely to die from this infection,” said vaccinologist Paul Offit.8 “We have to generate those data,” he said. “I can’t see how anybody—the Data and Safety Monitoring Board or the FDA Vaccine Advisory Committee, or FDA decision-makers—would ever allow a vaccine to be recommended for that group without having adequate data.”
“I feel the same way about minorities,” Offit added. “You can’t convince minority populations to get this vaccine unless they are represented in these trials. Otherwise, they’re going to feel like they’re guinea pigs, and understandably so.”
Acknowledgments
Sarah Tanveer helped research the design of studies and identify quotations, and Ulrich Keil provided comments on an early draft of this article.
Footnotes
- Competing interests: I co-wrote an op-ed on this topic with Eric Topol, who is quoted in this article, I have been pursuing the public release of vaccine trial protocols, and I co-signed an open letter to the FDA calling for independence and transparency in covid-19 vaccine related decision making.
- Provenance and peer review: Commissioned; externally peer reviewed.
This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usage
References
- ↵
- Shah A,
- Marks PW,
- Hahn SM
. Unwavering Regulatory Safeguards for COVID-19 Vaccines. JAMA2020.doi:10.1001/jama.2020.15725. pmid:32766736
Cavazzoni P, Marks P, Mayne S, et al. Senior FDA career executives: We’re following the science to protect public health in pandemic. USA Today. 2020 Sep 10. https://www.usatoday.com/story/opinion/2020/09/10/sound-science-to-meet-covid-challenges-fda-career-officials-column/5756948002.
Office of the Commissioner. The FDA’s Oversight of Vaccines is Vital to Public Health. 2020. https://www.fda.gov/news-events/fda-voices/fdas-scientific-and-regulatory-oversight-vaccines-vital-public-health
Hahn S. Remarks on the vaccine review process. 2020. https://www.fda.gov/news-events/speeches-fda-officials/dr-hahns-remarks-national-consumer-league-vaccine-review-process-09292020.
Sanofi. Biopharma leaders unite to stand with science. Sep 2020. http://www.news.sanofi.us/2020-09-08-Biopharma-leaders-unite-to-stand-with-science.
Palca J. What a nasal spray vaccine against covid-19 might do even better than a shot. NPR. 2020 Aug 28. https://www.npr.org/sections/health-shots/2020/08/28/906797539/what-a-nasal-spray-vaccine-against-covid-19-might-do-even-better-than-a-shot.
Curwen T. Those coronavirus vaccines leading the race? Don’t ditch the masks quite yet. Yahoo Finance. 2020. https://finance.yahoo.com/news/those-coronavirus-vaccines-leading-race-120006184.html.
Topol EJ. Paul Offit’s biggest concern about covid vaccines. 2020. https://www.medscape.com/viewarticle/936937.
Moderna TX. Protocol mRNA-1273-P301, Amendment 3. 2020. https://www.modernatx.com/sites/default/files/mRNA-1273-P301-Protocol.pdf.
Pfizer. PF-07302048 (BNT162 RNA-Based COVID-19 Vaccines) Protocol C4591001. 2020. https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-09/C4591001_Clinical_Protocol.pdf.
AstraZeneca. Clinical Study Protocol – Amendment 2 AZD1222- D8110C00001. 2020. https://s3.amazonaws.com/ctr-med-7111/D8110C00001/52bec400-80f6-4c1b-8791-0483923d0867/c8070a4e-6a9d-46f9-8c32-cece903592b9/D8110C00001_CSP-v2.pdf.
Janssen Vaccines & Prevention BV. VAC31518 (JNJ-78436735) clinical protocol VAC31518COV3001 amendment 1. 2020. https://www.jnj.com/coronavirus/covid-19-phase-3-study-clinical-protocol.
CDC. Coronavirus disease 2019 (COVID-19). 2020. http://web.archive.org/web/20200709001525/https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html.
CDC. What to do if you are sick. 2020. https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/steps-when-sick.html.
Moderna advances late-stage development of its vaccine (MRNA-1273) against covid-19. https://investors.modernatx.com/news-releases/news-release-details/moderna-advances-late-stage-development-its-vaccine-mrna-1273.
National Institutes of Health. Phase 3 clinical trial of investigational vaccine for COVID-19 begins. 2020. https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins.
Finn A, Malley R. A vaccine that stops covid-19 won’t be enough. New York Times. 2020 Aug 24. https://www.nytimes.com/2020/08/24/opinion/coronavirus-vaccine-prevention.html.
- ↵
- Trogen B,
- Oshinsky D,
- Caplan A
. Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA2020;323:2460-1. doi:10.1001/jama.2020.8917. pmid:32453392
THE STORY OF IVERMECTIN FOR KILLING COVID AND DENGUE
In 1975 a Japanese Professor by the name of Satoshi Omura discovered a microorganism called Streptomyces Avermitilisi in a sample of soil found on a golf course. During many painstaking years spent isolating and cultivating that specific strain, he enlisted the help of William C Campbell in the USA and formed a research collaboration of scientists across the world. In 1981, the drug IVERMECTIN was born.
Little did Omura know that ivermectin would be hailed next to penicillin and asprin as the three most important drugs in human history, or that he and Campbell would be awarded the 2015 Nobel Prize for medicine for their discovery of ivermectin.
Today, few people have heard of it. Vets and animal lovers may know it as a treatment for de-worming livestock. However, 250 million people worldwide have taken ivermectin, mainly the poorest of the poor who suffer from river blindness, a debilitating parasitic disease. It is also taken by humans for many other parasitic infections including lyme disease and viral infections such as malaria and dengue fever. The drug was given away free in many developing countries and side-effects are trivial and rare.
Despite decades of searching, nobody has been able to find another sample that matches Omura’s original. Luckily for the world, one sample was enough to develop the compound at extremely low cost. It is absolutely safe and is currently on the WHO’s list of ‘essential medicines.’ In March and April of 2020, doctors began publishing the benefits of ivermectin for treatment of covid and the NIH immediately responded by recommending it NOT be used outside of controlled trials.
This put the brakes on the treatment, but did not stop it as doctors familiar with ivermectin continued to use it as part of their covid treatments. In December 2020 Dr. Pierre Cory pleaded to the US senate to have it recommended as a treatment and prevention for covid. He presents a mountain of data from 4000 patients showing that it’s cheap, it’s available and it works. This is an emotional eight minutes of live testimony to watch: https://www.youtube.com/watch?v=YgOAaLmoa68.
Today, open source communities are lobbying the powers that be to make ivermectin freely available for worldwide use. In some countries, like India, it already is. In one region in Paraguay, the governor gave it the people under the guise of “a de-worming program” and covid numbers massively reduced. 40 published medical trials (16 peer reviewed) are available and many more studies are underway.
Sadly, the NIH still maintains its recommendation that it should not be used outside of clinical trials. This is ridiculous.
Crime Shouldn’t Pay: Why Big Tech Executives Should Face Jail
Mark Zuckerberg and Sundar Pichai need to be indicted.
|
Hi, Welcome to BIG, a newsletter about the politics of monopoly and finance. If you’d like to sign up, you can do so here. Or just read on… Today’s issue is about the various antitrust cases against Google and Facebook announced this week, and why it’s time to issue criminal indictments against the executives responsible for the bad behavior. Plus:
First, some house-keeping. Author and gadfly to the elites Anand Giridharadas interviewed me about the Facebook case. Also, antitrust lawyer Shaoul Sussman and I wrote a piece on a centrist scholar and historian named Herb Hovenkamp. Hovenkamp is not well-known outside the antitrust bar, but he is enormously influential within it, and it is his ideas that are structuring the dysfunctional environment in which we are operating. And now… The Antitrust Bonanza Against Google and FacebookIt’s hard not to be excited about the multiple antitrust suits filed this week against Google. This past Wednesday, Texas Attorney General Ken Paxton, along with 10 other state AGs, accused Google of monopolizing online advertising, arguing it used coercive tactics to seize control of the plumbing that underpins all ad-financed internet content, and illegally divided up the online ad market with Facebook. The next day, Colorado’s Phil Weiser and Nebraska’s Doug Peterson led 38 states in accusing Google of manipulating its search results to disfavor specialized competitors like Yelp, as well as blocking competitors who seek to enter new search markets like those of voice assistants or internet-enabled cars. The suits themselves are stunning. The Texas case reveals new details about how online advertising markets function, drawing from Dina Srinivasan’s critical research on how advertising sales has been transformed into a complex financial market run by Google. While the complaint alleges that Google has engaged in monopolization, it also alleges a different violation, that Facebook and Google are in a cartel to violate user privacy and fix prices in advertising markets. The complaint reveals that after Facebook bought WhatsApp, which pledged to its users (and the FTC) strict privacy controls, “Facebook signed an exclusive agreement with Google, granting Google access to millions of Americans’ end-to-end encrypted WhatsApp messages, photos, videos, and audio files.” If true, that’s a remarkable set of illegal acts, by both Google and Facebook, as well as a betrayal of their users. The complaint also asserts Google divided the ad market with Facebook, offering Facebook advantages in buying and selling ads through Google services if Facebook withdrew from head-to-head competition in other markets. This collusion is meaningful from a legal perspective. The Sherman Act has two parts. Section Two prohibits monopolization, but monopolization cases are very hard to bring and quite expensive, and require elaborate models. Section One prohibits cartels and price-fixing as conspiracies. Cartel cases are much easier – just show an agreement to collaborate on fixing prices, and you’re done. In fact cartels are so much easier to prosecute that price-fixing is the only area that enforcers actually bring criminal charges. And worrisome for Google, Texas is alleging cartel behavior. The Colorado-led suit, while not unearthing anything earth-shattering, is also quite useful. Enforcers there are addressing not just today’s search markets on desktop and mobile platforms, but where search is heading in the future, platforms like internet-enabled cars and voice assistants. It’s a smart way to ensure that antitrust enforcement blocks monopolization at the creation of new markets, which is when it’s easiest to generate competition. Since October, enforcers have brought four strong suits against Google and Facebook, two of the largest corporations in the world. And the demanded remedies for these civil violations are tough. Enforcers are asking for injunctive relief to stop the bad behavior, break-ups of these companies to end the structural conflicts, as well as monetary damages and civil fines.These few months represent perhaps the toughest spate of antitrust action since the post-World War II era, when Harry Truman restarted antitrust cases after their suspension during the war. It’s not just these suits; Apple is facing a major attack from Epic Games and a broad coalition who seeks to destroy its app store monopoly, and Congress is gearing up to smash monopolies through legislative efforts. As Steven Perlstein noted in the Washington Post, this effort is more than just an attack on Google and Facebook, but a “legal shot across the bow of dominant firms in other highly concentrated industries — pharmaceuticals, telecommunications, financial services — who are now on notice that their nonstop acquisitions and hardball business practices could invite similar challenge.” Even Europeans are getting more aggressive, with European member of Parliament Paul Tang winning a vote to ban personalized advertising in the EU, as well as offering increasing criticism of EU Competition enforcer Margarethe Vestager for lagging behind the tougher approach in the United States. It’s hard not to see the sharp turn in competition policy without a recognition that something has gone very very right in policy circles on the question of monopoly. And yet, there’s a fly in the ointment, as we move from the theoretical idea of antitrust against dominant corporations to the actual implementation. And that is, the suits are going to take a very long time. Crime PaysJudge Amit Mehta, who is hearing the case filed in October, said that the DOJ and Google will likely go to trial in late 2023. That’s nearly three years from now. The reason for the delay makes sense; both sides must gather documents, do research, file and debate procedural motions, interview executives and stakeholders, and build complex economic models for the trial. Still, three years is three years, and that’s a minimum. The trial itself could stretch out, with a remedy phase, and then there will be appeals. When all is said and done, it could be five years before there’s a remedy, or even longer. One problem with such a lengthy period is that the longer monopolistic behavior goes on, the more damage, in this case to publishers whose ad revenue is being stolen, and small and medium size businesses whose property is being appropriated. We can quantify the additional damages, somewhat. Google has $170B in revenue this year, and is growing on average at 10-20% a year. If we take the lower end of 10%, Google will add another $100 billion to its revenue by 2025. That’s a lot of money. Facebook is at $80 billion of revenue this year, but it is growing faster, so the net increase of revenue is a roughly similar amount. In other words, if the claims of the government are credible, then the lengthy case, while perhaps necessary, is also enabling these monopolists to steal an additional $100 billion apiece. Monopolization isn’t just illegal, it is in fact a crime, an appropriation of the rights and property of others by a dominant actor. The lengthy trial is essentially akin to saying that bank robbers getting to keep robbing banks until they are convicted, and can probably keep the additional loot. There are ways of a judge issuing preliminary orders to stop bad behavior in the interim, so it’s not inevitable that these corporations get to continue what they are doing. However, judges don’t tend to like issuing such orders, though hopefully enforcers will ask for them and Mehta will make an exception. But the monetary cost is not the most dangerous part of the delay. What’s more frightening is the political corruption that Google and Facebook are enabling. Thousands of newspapers have fallen apart over the past ten years, and over the next three, thousands more will collapse. Aside from killing pro-social institutions like newspapers, these platforms have been inducing significant harms society-wide, from enabling ethnic cleansing abroad and divisiveness in Western democracies, to undermining our economy writ large. The end state is frightening. Indeed, here’s what the Texas complaint alleges is Google’s long-term goal.
Google has total power over YouTube creators, the ability to demonetize them, to censor them, promote them or not. And that’s Google’s goal for all speakers and businesses online, to turn us all into serfs working – and speaking – at Google’s pleasure. It’s hard to argue that waiting five years for a remedy is sufficient to address this incredible threat to our wallets and more importantly our liberties. Now, this is not to say these cases won’t have an effect until they are concluded. I’ve pointed out that the DOJ suit is already having an effect, in that Google is now facing potential competition and changing its behavior to stop the most egregious exclusionary behavior. As scandal after scandal emerges around Google and Facebook, the political need for these companies to mitigate their behavior will increase. Legal scholar Tim Wu calls such a phenomenon the Policeman at the Elbow theory of antitrust enforcement, and there’s a lot of precedent. In the 1990s and early 2000s, during and after the antitrust case against Microsoft, Microsoft executives became far more cautious in product development, seeking legal advice to ensure they were not behaving in anti-competitive ways. Bill Gates recently noted that the reason people use iPhones and Android phones is because Microsoft was distracted by the case and so lost out on making Windows Mobile the standard. There’s a similar story with IBM, which unbundled software in the 1960s as a result of an antitrust case, thus enabling the creation of the modern software industry. Because of the policeman at the elbow watching their every move, Google and Facebook are going to have to incorporate legal advice into their product development patterns, and doing so is likely to increase opportunities for competitors. Still, there’s a difference between 2020 and earlier periods. Bill Gates, as hard as it is to believe, was more law-abiding than Zuckerberg and Pichai, because the rule of law was much stronger decades ago. Given legal uncertainty around the point of antitrust laws, as well as the political defiance of these leaders, it’s likely that Mark Zuckerberg and Sundar Pichai are going to work extremely hard to corrupt antitrust enforcement. They will do everything they can to *not* change their bad behavior, whether that’s ensuring products continue to exclude others, continuing a merger spree with more acquisitions (as Facebook just did), or even attempting to use their platforms to manipulate elections (as Uber and Lyft did with Prop 22 in California). We are in an era of elite lawlessness, so the normal effects of antitrust may not work until powerful leaders start to be afraid of getting caught breaking the law. And that’s what brings me to why we need to start talking about crime and punishment. The Problem of Elite LawlessnessIn the late 1930s, we had a similar period of elite lawlessness, a battle over the very legitimacy of the public’s right to vote for political change in the form of the New Deal. In the election of 1936, the banks, newspapers, and big business leaders combined through a variety of well-funded interest groups in an attempt to thwart FDR’s reelection. They lost. Two years later, in the midst of a recession, these leaders sought again to roll back New Deal rules as an unconstitutional seizures of power. Enter Thurman Arnold, the greatest antitrust enforcer in American history. Arnold was a Wyoming Democrat, but he was an iconoclast, both an ardent New Dealer and good friends and collaborator with Henry Simons, an anti-monopolist conservative at the University of Chicago who later helped found the Chicago School law and economics movement. Arnold was a press hound, believing that the public needed to understand antitrust law through the cases he would explain in the press. He shepherded the massive Alcoa monopoly suit through the courts and the press, and during World War II he would testify before Congress and accuse Standard Oil of New Jersey, among other giants, of collaborating with Nazis (which they were doing). In 1938, Arnold became the head of the antitrust division at the Department of Justice. He took a specific approach to bringing law and order back to the business community, which was to turn antitrust from a mere business problem to be handled by lawyers into a significant social stigma for executives. He would actually indict the executives themselves, fingerprinting them as common criminals. Arnold believed that“the only thing that would make businessmen behave was the threat of indictment.” And lo and behold, when he did so, all of a sudden there were lower prices in the and anti-competitive practices stopped. Arnold also believed in the political purpose of criminal prosecution for antitrust law. Political democracy, he believed, depended on what was known at the time as “industrial democracy,” meaning open competitive markets in which ordinary people could participate. Monopolization and cartelization prevented that, and thus should be blocked through either civil or criminal proceedings to ensure the rules of business preserved fairness and safety. After all, Arnold asked, antitrust represented the “red lights of business traffic, and why shouldn’t we seek criminal indictments if traffic violations are criminal offenses?” The strategy Arnold pursued worked remarkably well. He would “hit hard, hit everyone and hit them all at once,” bringing both criminal indictments and civil charges concurrently to everyone in the industry at all layers who were involved in anti-competitive practices, and then offering a consent decree to restructure the industry. Businessmen would practically line up outside his office, and sign whatever he put in front of them, and his approach ended up changing the “building and construction, motion picture, tire, fertilizer, petroleum, and transportation industries,” among others. By going after bad behavior by big business, Arnold became one of the most popular New Dealers in the country. Yet while Arnold is often lauded as a great antitrust enforcer, his true legacy is much more important than that. Along with other New Dealers, he helped end the crime spree that had taken place among business and banking elites. Today, we face a similar crime spree. As Gilead Edelman wrote in Wired on the deal between Facebook and Google to divide up the ad market, “If what Texas is alleging is true, then both companies may have violated federal antitrust law—and committed felonies in the process.” The Value of HandcuffsAnd that gets to the basic point. What Facebook and Google are doing is crime, and it needs to be treated as such. Right now, Mark Zuckerberg and Sundar Pichai believe that they have to fight a civil case, which means spending money on lawyers and being deposed by government officials. But they will keep their wealth, and of course, their freedom, because they are personally not at risk, so scheming to dominate more markets elsewhere is a perfectly reasonable activity to pursue even while their companies are on trial. Violating the law by taking someone else’s livelihood risks, at worst, a parking ticket. But if these men were facing the prospect of personal criminal liability, then the stakes would suddenly shift. During the trial, they would become far more cautious and unwilling to engage in potentially predatory actions, for fear of losing their wealth and freedom, much as they have appropriated that of others. And their lawyers would start giving them different advice on what is legal and what is not when they come to key business decisions. Moreover, using criminal laws creates a different dynamic and gives enforcers investigative tools that don’t exist for civil suits. The DOJ Antitrust Division has a policy called the “Corporate Leniency Policy,” which lets cartel participants get leniency if they tell the division about the conspiracy, thus creating an incentive for wrongdoers to tell the DOJ about crimes in action. If enforcers began to bring real criminal indictments against big tech executives for monopolization, they would be able to flip executives in ways they cannot now do. Imagine any number of Facebook or Google employees, aware of attempts to monopolize and suddenly afraid of being put in jail if they don’t come forward and tell enforcers what they know. I suspect that any problems Zuckerberg or Pichai have with employees would be magnified dramatically if employees feared they might face charges as co-conspirators in a criminal act. Enforcers can use the Sherman Antitrust Act to bring criminal charges, as the law is both a criminal and a civil statute. At some point prior to the 1980s, enforcers stopped bringing criminal provisions to address monopolization, but they do bring criminal charges for price-fixing among cartels. The Antitrust Division recently indictedchicken company execs for price-fixing, though they basically consider monopolization a purely civil wrong. In my view, that is a mistake, with the criminal aspect of the Sherman Act yet one more dormant legal tool lying fallow. Indeed, some of the biggest cases ever brought, like the case against the A&P supermarket chain in the 1940s (which was the Walmart or Amazon of its day), included criminal monopolization charges. Though I think pushing the boundaries of the law is useful, it is not necessary to pioneer a new use of the Sherman Act’s monopolization provisions to bring criminal charges against big tech executives. Price-fixing is already per se illegal, and the DOJ Antitrust Division often does indict people for engaging in this kind of cartel behavior, and price-fixing is one thing Texas accused Google and Facebook of doing. But you don’t even have to use the antitrust laws, because there are ample and routine violations of law happening on a regular basis. Last year, for instance, Facebook paid $40 million over accusations it inflated video viewing metrics, which is another way of saying it likely committed fraud against advertisers. But there are many other areas of likely wrongdoing to explore. There are also plenty of investigations going on, and potential fodder for action. Last week, for instance, the Federal Trade Commission issued a little noticed request for information from nine social media and video streaming services: Amazon, TikTok, Discord, Facebook, Reddit, Snap, Twitter, WhatsApp, and YouTube. One of the sections was a request for information about false accounts, inaccuracies in metrics for advertisers, revenue value of errors, and senior leadership involvement in oversight. Who knows what that will unearth? The bottom line is that criminal enforcement is in fact critical to redressing the lawlessness we’re seeing among business leaders, because we need both a safe environment for non-predatory business, and a strong statement about the rule of law itself. Monopolization is a crime. It’s time to start treating it as such. The End of Private Equity Is Coming: I’ve noted that large leveraged buyouts are fool’s gold, and that investors are coming to understand that they aren’t getting a great deal when they put their money into large PE funds. That’s a problem for PE titans because they need pension fund money. But now another part of the model is coming under attack. Leveraged buy-out funds use investor capital to loot companies by loading them up with debt they often know cannot be paid back, in what are known as ‘dividend recapitalizations.’ When a PE fund burns down a subsidiary company by loading it up with debt and paying itself a big dividend, creditors, and the corporation’s customers and workers, get stiffed. Last week, Judge Jed Rakoff struck at the heart of this corrupt model, allowing creditors to go after the private equity middlemen who intentionally default
Rakoff is a great judge, but he can be overturned on appeal. So we’ll see what happens. And thanks to the Fed, Dividend recaps are returning in force. So this is another footrace between corruption and the rule of law. New Jersey Health Insurance: For New Jersey residents, BIG reader Joseph Ingemi had a piece on why the New Jersey state legislature should address its health insurer/hospital monopoly problem and how to do so. Netflix and Swindle: Netflix is getting big local subsidies from New Mexico to locate production there, but there’s a race among a lot of states to attract film production. Georgia apparently spent $4 billion over the last ten years giving money to studios. It’s about time for states to band together and end this subsidy game. Thanks for reading. Send me tips, stories I’ve missed, or comment by clicking on the title of this newsletter. And if you liked this issue of BIG, you can sign up here for more issues of BIG, a newsletter on how to restore fair commerce, innovation and democracy. If you really liked it, read my book, Goliath: The 100-Year War Between Monopoly Power and Democracy. cheers, Matt Stoller P.S. I got an interesting note from former Amazon Web Services employee Tim Bray, a brilliant engineer who has been writing about how to break up both Amazon and Google. He corrected my argument on the rise of Slack, and threw cold water all over blockchain technology.
|
Messengers of Gates’ Agenda: How the Cornell Alliance for Science Spreads Disinformation on behalf of the Bill and Melinda Gates Foundation
by Heather Day/AGRA Watch
In October of this year, the Cornell Alliance for Science (CAS) hosted a webinar on “agroecology,” a concept that has attracted growing attention in recent years. Agroecology is a transdisciplinary science, practice, and social movement that offers a pathway for food system transformation. Yet, as soon as the webinar began, the moderator contrasted “scientific” definitions of agroecology as legitimate whereas social movement type definitions were labeled “ideological.” From what we have learned about the Cornell Alliance for Science, this was not surprising; the webinar was just their latest tactic in what is a well-funded disinformation campaign to co-opt and neuter the transformative concept of agroecology, while promoting agribusiness-driven solutions to agriculture through proprietary science and technological innovation. In fact, it was for this very reason that just three days before, two agroecologists that had been invited to participate stepped down from the panel, citing bias.
The Cornell Alliance for Science was founded with funding from the Bill and Melinda Gates Foundation (BMGF), which has emerged over the past decade as perhaps the single most influential actor in an ever-intensifying battle over the future of food and agriculture.
The BMGF has been pumping major funding into industrial agriculture while also creating powerful alliances seeking to reconfigure global governance of the food system. While some of the Gates Foundation’s agriculture-related activities are drawing increasing scrutiny, we recently examined an important but under explored aspect of BMGF’s strategy: How it is framing food system debates, shaping how issues are communicated, and fostering a new generation of ‘leaders’ to carry forward its mission.
Our report, Messengers of Gates’ Agenda: A Case Study of the Cornell Alliance for Science Global Leadership Fellows Program, demonstrates how the Gates Foundation achieves these aims by commissioning CAS to train communications professionals to disseminate biotech industry propaganda, including by discrediting agroecology; all masquerading as promoting and advancing science. CAS thereby uses its affiliation with Cornell, the only ivy league institution that is also a land-grant college, to claim scientific neutrality while assiduously promoting communications aligned with agribusiness.
Training Gates Foundation Messengers
Housed in Cornell’s College of Agriculture and Life Sciences in Ithaca, New York, CAS was launched in 2014 via a $5.6 million grant from the Gates Foundation. Its stated mission is “to promote access to scientific innovation as a means of enhancing food security, improving environmental sustainability and raising the quality of life globally.”[1] According to CAS director Sarah Evanega, CAS aims to “depolarize the GMO debate and engage with potential partners who may share common values around poverty reduction and sustainable agriculture, but may not be well informed about the potential biotechnology has for solving major agricultural challenges.”[2]
The Gates Foundation granted an additional $6.4 million to CAS in 2017, and, in Sept 2020, $10 million more.[3] BMGF remains the overwhelming primary funder of CAS to date, although fifteen additional institutional and individual contributors of $1000 or more are listed on the CAS website.
CAS describes its main strategies as a) establishing a global network; b) “training with a purpose”; and c) developing multimedia communications on agricultural biotechnology. These strategies come together through its Global Leadership Fellows Program, a 12-week intensive training course held each year at Cornell. This brings together 20–30 young professionals, mainly from the Global South, and particularly Africa. While the geographical reach of the program has been broadening, the majority of fellows – 60% in 2019 – were of African origin, in keeping with prior years (See Figure 1). Moreover, examination of the fellows’ affiliations indicate multiple linkages with BMGF. Cross checking the fellows’ affiliations with grant disbursement data provided on the BMGF website, we can see that 34% of all the African fellows from 2015–2019 were associated with organizations that received funding from BMGF. Together, organizations connected to the fellows received over $712 million from BMGF from 2003 through 2019.
“Alliance for Science” is a Misnomer
The strong overlap between the groups funded by BMGF for its agricultural development projects and the CAS fellows gives additional meaning to the CAS strategy of building a global network, begging the question, whom does this network serve, and toward what ends?
Given these linkages, it comes as little surprise that there are strong parallels between the types of technologies promoted by BMGF through its agricultural investments and the messages coming from CAS and its fellows. In analyzing the work put out by CAS and its fellows, an obvious pattern emerges: an uncritical promotion of biotechnology. Furthermore, in a distortion of scientific methodology and its own stated purpose, this position is not vetted against any diverging ones. What adds power to the narratives of CAS it is that its messages appear not to be coming from BMGF or from its agribusiness partners directly, but from mostly young, African voices that make up its Fellowship Program, ostensibly informed by their lived experiences and claimed scientific rigor, provided by the affiliation with Cornell.
The patent bias of CAS has similarly been critiqued by members of the Cornell faculty,[4] student body[5] and broader Cornell and Ithaca community. According to Jonathan Latham of the Ithaca-based Bioscience Resource Project, “Of several hundred talks at Cornell sponsored by the Alliance, only one has ever offered a contrary view. Worse, most of its guests are simply corporate propagandists who have nothing, academically, to offer. For an organization that claims to be a promoter of debate, that it is a remarkably lop-sided record.”[6]
This matters in terms of how these messages are received by the public. Communications studies have demonstrated that the public is more likely to be receptive to a message when it believes it has come from independent scientists as opposed to originating with industry.[7] Perhaps this is why CAS goes to great lengths in its publicity materials to distance itself from the biotech industry, despite its industry links.[8]
Manufacturing Doubt about Agroecology
In all, it seems obvious that, through its funding for the Cornell Alliance for Science, the Bill and Melinda Gates Foundation is seeking to shape public opinion in favor of adopting GMOs and corporate agriculture. A key communications strategy of CAS is to promote narratives in which biotechnology is equated with ‘science’. Conversely, critiquing biotechnology is equated with being ‘anti-science.’ In our case study, we teased out how this strategy was employed by one CAS Fellow, Nassib Mugwanya, in his February 2019 article entitled ‘After Agroecology: Why Traditional Agricultural Practices Can’t Transform African Agriculture’. We identified four false narratives employed by Mugwanya: Agroecology can be characterized as a particular, limited set of agricultural practices; it involves a glorification of the past and a rejection of the modern; it is being imposed upon African farmers from outside of Africa, and it will keep farmers locked into poverty and drudgery.
The overall message left with readers of Mugwanya’s article can be summed up as follows:Agroecology is being foisted upon unsuspecting African farmers from the outside – by wealthy NGOs that romanticize peasant lifestyles. Claims of the benefits of agroecology are not well grounded in science. What farmers really need is biotech and accompanying technological packages, and agroecology is dangerous and immoral for serving as an impediment to this. It is important for agroecology advocates in Africa and elsewhere to understand that this is the type of messaging they are up against – packaged to represent the cutting edge of science-based communication.
That the attacks on agroecology by CAS are coming at the same time that there is a mounting global scientific consensus around the merits of agroecology is no coincidence. Studies have demonstrated that perceived scientific consensus is a key factor in influencing public support on a given issue and that this tends to encourage counter-efforts around “the ‘manufacture of doubt’ by political and vested interests.”[9] As momentum continues to build around agroecology, its advocates can be certain that further smear campaigns and other attempts to manufacture doubt will continue.
It should come as no surprise that philanthro-capitalists like Bill and Melinda Gates fund propaganda to further the corporate-controlled agricultural model that their foundation promotes. Beware the messengers of their agenda, who are the graduates of the Cornell Alliance for Science Global Fellows program.
Download the 34 page report, published August 2020: Messengers of Gates’ Agenda: A Case Study of the Cornell Alliance for Science Global Leadership Fellows Program. By AGRA Watch, a campaign of the Community Alliance for Global Justice (CAGJ) which is based in Seattle, Washington, USA. Heather Day is Executive Director of CAGJ.
Efficacy and Safety of Tetrahydrocurcuminoids for the Treatment of Canker Sore and Gingivitis
Sami-Sabinsa Group (India), December 16, 2020
Abstract
Background. Tetrahydrocurcuminoids (THCs) are among the major metabolites of curcuminoids with a higher bioavailability and physiological stability and exhibit a broad spectrum of therapeutic activities. The objective of this study was to evaluate the efficacy of THCs in patients suffering from canker sore and gingivitis designed as an exploratory clinical trial. Methods. This is an open label prospective pilot clinical trial carried out at two clinical centers: Noble Hospital, Pune, Maharashtra, and Sri Venkateshwara Hospital, Bangalore, Karnataka in India. Participants were assigned to 21 days of treatment with chewable oral THCs supplement. Patients were instructed to self-administer one chewable tablet containing 100 mg of THCs twice daily for up to 21 days. This clinical trial was registered at a public Clinical Trial Registry in India (http://www.ctri.nic.in). Thirty-one canker sore and twenty-nine gingivitis patients participated in this study. Body mass index, throat numbness/relief, Visual Analog Scale (VAS) pain score, canker sore lesions, gingival appearance, inflammation and bleeding were assessed before and after treatment, at 14 and 21 days. Vital signs and laboratory parameters were assessed for safety. Results. THCs treatment significantly reduced the reddening at the site, difficulty in chewing, swallowing, and VAS pain score in the canker sore patients. Further, both single and multiple lesions were completely healed. In gingivitis patients, gingival appearance, bleeding, and inflammation were significantly reduced. No adverse effects were observed during the study. Conclusion. Overall, the findings of this study show that supplementation of THCs for 21 days reduced the pain and prevented the progression of the disease in patients suffering from canker sore and gingivitis without adverse side effects
Stress in adolescence leads to learning and memory difficulties and increased anxiety in adulthood
Federal Polytechnic School of Lausanne (Switzerland), December 14, 2020
This work has investigated the long-term consequences of stress experienced at this critical period of life in rodents, in collaboration with the Behavioural Genetics laboratory at the Brain and Mind Institute of the Federal Polytechnic School of Lausanne (Switzerland), led by the Spanish researcher Carmen Sandi.
The study also shows that it is the capacity of recovery of corticosterone basal levels -the equivalent of cortisol in humans- released in response to repeated stress in adolescence, and not the amount of this hormone released, that predicts the degree of learning impairment that will be experienced in adulthood.
“Testing spatial learning in rats is a way of assessing cognitive, memory and learning skills in the laboratory” explains Dr. Márquez. This learning goes beyond the academic knowledge and extends to all facets of daily life.
Stress regulation
In the study, rats that showed a poorer recovery from stress in the early stages of life had higher levels of PSA-NCAM, suggesting a neurobiological mechanism by which peripubertal stress would alter the normal maturation of plasticity processes in specific regions of the brain, such as the hippocampus, leading to a deterioration in cognitive performance and the appearance of anxiety-related behaviours later in life.
Overall, the results of this study demonstrate that the peripubertal period would be a critical time window in which stress may lead to long-term changes in the reactivity of the hypothalamus-pituitary-adrenal axis, which would be underlying the difficulties in learning abilities observed in adult life.
“Our results suggest that the degree of stress-induced adaptation of the hypothalamus-pituitary-adrenal axis in the important transition period of puberty is related to the long-term programming of cognition, behaviour and endocrine reactivity,” says Dr Stamatina Tzanoulinou, first author of the study.
These findings pave the way for new studies that can identify mechanisms of both vulnerability and resilience to early trauma: “The programming effects of early stress may need an incubation period that can be reversed in young and more plastic brains, but not during adulthood. Therefore, following early detection of individuals vulnerable to stress, there could be a window of opportunity for therapeutic intervention in adolescence to avoid the natural course into psychopathology and cognitive impairment”, highlights Dr Marquez.
Investigating how 6-gingerol and gamma-tocotrienol can suppress cancer growth
Universiti Kebangsaan Malaysia, December 18, 2020
Malaysian researchers investigated the mechanisms underlying the anti-cancer effects of a combination treatment of y-tocotrienol and 6-gingerol. They reported their findings in an article published in the Journal of Natural Medicines.
- In their previous study, the researchers reported that y-tocotrienol (yT3) and 6-gingerol (6G) synergistically inhibited the proliferation of human colorectal cancer cells.
- To elucidate the mechanisms involved in this suppression, they used RNA sequencing techniques and conducted transcriptome analysis of the total RNA from both untreated and yT3 + 6G-treated SW837 cancer cells.
- High-throughput sequencing was performed at approximately 30 to 60 million coverage.
- The researchers found that changes in cancer-specific gene expression occurred in the yT3 + 6G-treated cells.
- Functional enrichment pathway analysis also suggested that the combination of yT3 and 6G modulated more than one pathway.
- yT3 + 6G interfered with the cell cycle process, downregulated the Wnt signaling pathway and induced caspase-independent apoptosis by inducing mitochondrial dysfunction, activating the endoplasmic reticulum (ER) unfolded protein response (UPR), disrupting DNA repair mechanisms and inactivating the cell cycle.
- The latter, noted the researchers, was made possible by the downregulation of proliferation-related genes like FOXM1.
- Meanwhile, yT3 + 6G exerted a cytotoxic effect by upregulating genes involved in stress response activation.
- The combination treatment also exerted cystostatic effects by downregulating the main regulator genes in the cell cycle.
- RNA sequencing and RT-qPCR results revealed that genes like ATF6, DDIT3, GADD34, FOXM1, CDK1 and p21, which are involved in stress response-, apoptosis- and proliferation-related pathways, displayed concordant patterns of gene expression.
Based on these findings, the researchers concluded that bioactive compounds like y-tocotrienol and 6-gingerol can be used to effectively suppress cancer cell growth.
Maternal anxiety affects the fetal brain
Childrens National Hospital (in DC). December 8, 2020
Anxiety in gestating mothers appears to affect the course of brain development in their fetuses, changing neural connectivity in the womb, a new study by Children’s National Hospital researchers suggests. The findings, published Dec. 7, 2020, in JAMA Open Network, could help explain longstanding links between maternal anxiety and neurodevelopmental disorders in their children and suggests an urgent need for interventions to diagnose and decrease maternal stress.
Researchers have shown that stress, anxietyor depression in pregnant mothers is associated not only with poor obstetric outcomes but also social, emotional and behavioral problems in their children. Although the care environment after birth complicates the search for causes, postnatal imaging showing significant differences in brain anatomy has suggested that these problems may originate during gestation. However, direct evidence for this phenomenon has been lacking, says Catherine Limperopoulos, Ph.D., director of the Developing Brain Institute at Children’s National.
To help determine where these neurological changes might get their start, Dr. Limperopoulos, along with staff scientist Josepheen De Asis-Cruz, M.D., Ph.D., and their Children’s National colleagues used a technique called resting-state functional magnetic resonance imaging (rs-fMRI) to probe developing neural circuitry in fetuses at different stages of development in the late second and third trimester.
The researchers recruited 50 healthy pregnant volunteers from low-risk prenatal clinics in the Washington, D.C. area who were serving as healthy “control” volunteers in a larger study on fetal brain development in complex congenital heart disease. These study participants, spanning between 24 and 39 weeks in their pregnancies, each filled out widely used and validated questionnaires to screen for stress, anxiety and depression. Then, each underwent brain scans of their fetuses that showed connections between discrete areas that form circuits.
After analyzing rs-fMRI results for their fetuses, the researchers found that those with higher scores for either form of anxiety were more likely to carry fetuses with stronger connections between the brainstem and sensorimotor areas, areas important for arousal and sensorimotor skills, than with lower anxiety scores. At the same time, fetuses of pregnant women with higher anxiety were more likely to have weaker connections between the parieto-frontal and occipital association cortices, areas involved in executive and higher cognitive functions.
“These findings are pretty much in keeping with previous studies that show disturbances in connections reported in the years and decades after birth of children born to women with anxiety,” says Dr. De Asis-Cruz. “That suggests a form of altered fetal programming, where brain networks are changed by this elevated anxiety even before babies are born.”
Whether these effects during gestation themselves linger or are influenced by postnatal care is still unclear, adds Dr. Limperopoulos. Further studies will be necessary to follow children with these fetal differences in neural connectivity to determine whether these variations in neural circuitry development can predict future problems. In addition, it’s unknown whether easing maternal stress and anxiety can avoid or reverse these brain differences. Dr. Limperopoulos and her colleagues are currently studying whether interventions that reduce stress could alter the trajectory of fetal neural development.
In the meantime, she says, these findings emphasize the importance of making sure pregnant women have support for mental health issues, which helps ensure current and future health for both mothers and babies.
“Mental health problems remain taboo, especially in the peripartum period where the expectation is that this is a wonderful time in a woman’s life. Many pregnant mothers aren’t getting the support they need,” Dr. Limperopoulos says. “Changes at the systems level will be necessary to chip away at this critical public health problem and make sure that both mothers and babies thrive in the short and long term.”
Meta-analysis finds greater dietary fiber intake associated with significantly lower risk of depression
Iran University of Medical Sciences, December 10, 2020
According to news originating from Tehran, Iran, research stated, “A potential relationship between depression and the intake of dietary fiber has been hypothesized in several studies. However, no meta-analysis has been conducted so far to explore the association between these two variables.”
Our news journalists obtained a quote from the research from the Iran University of Medical Sciences, “Hence, we designed the present meta-analysis to elucidate the relationship between the intake of dietary fiber and depression. A comprehensive search was performed using the PubMed/Medline, Scopus, Web of Science and Google Scholar databases to identify any relevant studies published from inception to October 2019. Observational studies (cross-sectional and case-control) were included in the analysis. Pooled analysis from the random-effects model of four case-control studies revealed that the consumption of dietary fiber in patients with depression was significantly lower versus healthy controls (WMD: -1.41 mg/dl, 95% CI: -2.32, -0.51, p=0.002). No significant heterogeneity was demonstrated among the analyzed studies (I=4.0%, p=0.37). By pooling 5 effect sizes of cross-sectional studies (with a total of 97023 subjects), we demonstrated that a higher dietary consumption of fiber was associated with significantly lower odds of depression (OR=0.76; 95% CI: 0.64, 0.90; p=0.010), with a low heterogeneity seen among the retrieved studies (I=43.9%; p=0.12). An increased intake of total dietary fiber is associated with lower odds of depression.”
According to the news editors, the research concluded: “Further studies are needed to evaluate the relationship between the different types of dietary fiber and depression.”
This research has been peer-reviewed.
Vitamin D the clue to more Autism spectrum disorder in boys
University of Queensland, December 14, 2020
A deficiency in Vitamin D on the mother’s side could explain why Autism spectrum disorder is three times more common in boys, say researchers from The University of Queensland.
In their latest study, Professor Darryl Eyles and Dr Asad Ali from UQ’s Queensland Brain Institute found vitamin D deficiency during pregnancy caused an increase in testosterone in the developing brain of male rats.
“The biological cause of Autism spectrum disorder (ASD) is unknown but we have shown that one of the many risk factors–low vitamin D in mothers–causes an increase in testosterone in the brain of the male foetuses, as well as the maternal blood and amniotic fluid,” Professor Eyles said.
“In addition to its role in calcium absorption, vitamin D is crucial to many developmental processes.
“Our research also showed that in vitamin D-deficient male foetuses, an enzyme which breaks down testosterone was silenced and could be contributing to the presence of high testosterone levels.”
Professor Eyles’ previous research has shown that vitamin D plays a critical role in brain development and that that giving vitamin D supplements to mice during pregnancy completely prevented ASD-like traits in their offspring.
Co-author Dr Ali said that excessive exposure of the developing brain to sex hormones like testosterone was thought to be an underlying cause of ASD, but the reasons remained unclear.
“Vitamin D is involved in pathways controlling many sex hormones,” Dr Ali said.
“When the rat mothers were fed a low vitamin D diet, it caused male foetal brains to have high levels of exposure to testosterone.”
Professor Eyles said the study was the first to show that a known risk factor for ASD alters testosterone in both the foetal brain and the mother’s blood — one possible contributor to why ASD is more prevalent in males.
“We have only studied one risk factor for ASD — vitamin D deficiency during development — our next step is to look at other possible risk factors, such as maternal stress and hypoxia – lack of oxygen – and see if they have the same effect,” he said.
Melatonin rescues dendrite collapse in cells treated with pro-oxidant compound that elicits alterations found in Alzheimer disease
National Institute of Psiquiatria Ramon de la Fuente Muniz (Mexico), December 16, 2020
According to news reporting originating from Mexico City, Mexico, research stated, “The pro-oxidant compound okadaic acid (OKA) mimics alterations found in Alzheimer’s disease (AD) as oxidative stress and tau hyperphosphorylation, leading to neurodegeneration and cognitive decline. Although loss of dendrite complexity occurs in AD, the study of this post-synaptic domain in chemical-induced models remains unexplored.”
Our news editors obtained a quote from the research from Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz: “Moreover, there is a growing expectation for therapeutic adjuvants to counteract these brain dysfunctions. Melatonin, a free-radical scavenger, inhibits tau hyperphosphorylation, modulates phosphatases, and strengthens dendritic arbors. Thus, we determined if OKA alters the dendritic arbors of hilar hippocampal neurons and whether melatonin prevents, counteracts, or reverses these damages. Rat organotypic cultures were incubated with vehicle, OKA, melatonin, and combined treatments with melatonin either before, simultaneously, or after OKA. DNA breaks were assessed by TUNEL assay and nuclei were counterstained with DAPI. Additionally, MAP2 was immunostained to assess the dendritic arbor properties by the Sholl method.”
According to the news editors, the research concluded: “In hippocampal hilus, OKA increased DNA fragmentation and reduced the number of MAP2(+) cells, whereas melatonin protected against oxidation and apoptosis. Additionally, OKA decreased the dendritic arbor complexity and melatonin not only counteracted, but also prevented and reversed the dendritic arbor retraction, highlighting its role in post-synaptic domain integrity preservation against neurodegenerative events in hippocampal neurons.”
